[go: up one dir, main page]

TW202411409A - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element capable of obtaining a liquid crystal alignment film having high mechanical strength - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element capable of obtaining a liquid crystal alignment film having high mechanical strength Download PDF

Info

Publication number
TW202411409A
TW202411409A TW112128726A TW112128726A TW202411409A TW 202411409 A TW202411409 A TW 202411409A TW 112128726 A TW112128726 A TW 112128726A TW 112128726 A TW112128726 A TW 112128726A TW 202411409 A TW202411409 A TW 202411409A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
polymer
group
organic group
Prior art date
Application number
TW112128726A
Other languages
Chinese (zh)
Inventor
福田一平
日向野敏行
Original Assignee
日商日產化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學股份有限公司 filed Critical 日商日產化學股份有限公司
Publication of TW202411409A publication Critical patent/TW202411409A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09FDISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F9/00Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements
    • G09F9/30Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements in which the desired character or characters are formed by combining individual elements
    • G09F9/35Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements in which the desired character or characters are formed by combining individual elements being liquid crystals

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Mathematical Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Theoretical Computer Science (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

The present invention provides a liquid crystal alignment agent capable of obtaining a liquid crystal alignment film having high mechanical strength even when using substituted cyclobutane tetracarboxylic dianhydride or its derivatives as raw materials to obtain a polyimide liquid crystal alignment film, and provides the liquid crystal alignment film and the liquid crystal display element using the liquid crystal alignment film. A liquid crystal alignment agent is characterized by containing a polymer (A). The polymer (A) is at least one selected from a group consisting of a polyimide precursor having a repeating unit (a1) represented by formula (1) and a polyimide that is an imide product of the polyimide precursor. R and Z each independently represent a hydrogen atom or a monovalent organic group.

Description

液晶配向劑、液晶配向膜及液晶顯示元件Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

本發明係關於液晶配向劑、液晶配向膜及液晶顯示元件。The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element.

液晶顯示裝置廣泛作為個人電腦、智慧手機、行動電話、電視等的顯示部使用。液晶顯示裝置,通常具備:夾持在顯示元件基板與彩色濾光片基板之間之液晶層、對於液晶層施加電場之畫素電極及共通電極、控制液晶層之液晶分子之配向性之配向膜、開關對於畫素電極供給之電信號之薄膜電晶體(TFT)等。液晶分子之驅動方式已知有:TN方式、VA方式等縱電場方式、IPS(面內開關,In Plane Switching)驅動方式、FFS(邊緣場開關,Fringe Field Switching)驅動方式等橫電場方式。Liquid crystal display devices are widely used as display parts of personal computers, smart phones, mobile phones, televisions, etc. Liquid crystal display devices usually have: a liquid crystal layer sandwiched between a display element substrate and a color filter substrate, a pixel electrode and a common electrode for applying an electric field to the liquid crystal layer, an alignment film for controlling the alignment of liquid crystal molecules in the liquid crystal layer, and a thin film transistor (TFT) for switching the electrical signal supplied to the pixel electrode. The known driving methods of liquid crystal molecules include: longitudinal electric field methods such as TN method and VA method, lateral electric field methods such as IPS (In Plane Switching) driving method and FFS (Fringe Field Switching) driving method.

工業上最普及的液晶配向膜,係藉由將形成在電極基板上之由聚醯胺酸及/或將其予以醯亞胺化而得之聚醯亞胺構成之膜之表面以綿、尼龍、聚酯等布沿一方向摩擦之所謂摩擦處理來製作。摩擦處理係簡便且生產性優異之工業上有用的方法。但是伴隨液晶顯示元件之高性能化、高精細化、大型化,摩擦處理產生之配向膜之表面之傷痕、起塵、機械力、靜電所致之影響,更而配向處理面內之不均勻性等各種問題變得明顯。作為替代摩擦處理之配向處理方法,已知有藉由照射經偏光之放射線來賦予液晶配向能力之光配向法。針對光配向法,已有人提出利用光異構化反應之方法、利用光交聯反應之方法、利用光分解反應之方法等(例如:參照非專利文獻1、專利文獻1、2)。 近年來,高精密的平板PC、汽車導航這類小型之顯示端末成為主體,對於液晶顯示元件之高品質化之要求比以往更高。尤其就汽車導航等車載用途之液晶顯示元件之可靠性試驗而言,有時會實施面板的振動試驗。此振動試驗,要求不發生亮點等不良。為了獲得振動試驗後不產生不良的液晶顯示元件,有人考量例如提高液晶配向膜之機械強度之方法。 [先前技術文獻] [專利文獻] The most popular liquid crystal alignment film in industry is produced by rubbing the surface of a film composed of polyamide and/or polyimide obtained by imidization formed on an electrode substrate with a cloth such as cotton, nylon, polyester, etc. in one direction. The rubbing treatment is a simple and productive method that is useful in industry. However, with the high performance, high precision, and large-scale development of liquid crystal display elements, various problems such as scratches, dust, mechanical force, and static electricity on the surface of the alignment film produced by the rubbing treatment have become apparent, as well as the unevenness within the alignment treatment surface. As an alignment treatment method that replaces the rubbing treatment, a photoalignment method is known that imparts alignment ability to liquid crystals by irradiating polarized radiation. Regarding the photoalignment method, some have proposed methods using photoisomerization reaction, methods using photocrosslinking reaction, methods using photodecomposition reaction, etc. (for example, refer to non-patent document 1, patent documents 1, 2). In recent years, small display terminals such as high-precision tablet PCs and car navigation have become the mainstay, and the requirements for high-quality liquid crystal display elements are higher than ever before. In particular, for reliability testing of liquid crystal display elements for automotive applications such as car navigation, vibration tests of the panels are sometimes performed. This vibration test requires that no defects such as bright spots occur. In order to obtain a liquid crystal display element that does not produce defects after the vibration test, some people have considered methods such as improving the mechanical strength of the liquid crystal alignment film. [Prior technical literature] [Patent literature]

[專利文獻1]日本特開平9-297313號公報 [專利文獻2]日本特開2004-206091號公報 [非專利文獻] [Patent Document 1] Japanese Patent Publication No. 9-297313 [Patent Document 2] Japanese Patent Publication No. 2004-206091 [Non-patent Document]

[非專利文獻1]「機能材料」,1997年11月號,Vol.17,No.11,13~22頁[Non-patent document 1] "Functional Materials", November 1997, Vol.17, No.11, pp.13-22

(發明欲解決之課題)(The problem to be solved by the invention)

本案發明人檢討後,明白使用經取代之環丁烷四羧酸二酐或其衍生物為原料而獲得之習知聚醯亞胺液晶配向膜,若考量到未來機械強度特性更提升之要求,未必能得到可因應高水平要求者。After reviewing, the inventors of the present case realized that the conventional polyimide liquid crystal alignment film obtained by using substituted cyclobutanetetracarboxylic dianhydride or its derivatives as raw materials may not be able to meet the high-level requirements if the requirements for higher mechanical strength properties are taken into consideration in the future.

而本發明有鑑於上述情事,目的為提供可獲得即使是使用經取代之環丁烷四羧酸二酐或其衍生物為原料獲得之聚醯亞胺液晶配向膜仍為高機械強度之液晶配向膜的液晶配向劑、該液晶配向膜、及使用了該液晶配向膜之液晶顯示元件。 (解決課題之方式) The present invention is made in view of the above circumstances, and aims to provide a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element using the liquid crystal alignment film, which can obtain a liquid crystal alignment film having high mechanical strength even when the polyimide liquid crystal alignment film is obtained using substituted cyclobutanetetracarboxylic dianhydride or its derivatives as raw materials. (Method for solving the problem)

本案發明人努力研究,發現藉由使用含有特定成分之液晶配向劑,能夠解決上述課題,乃完成本發明。The inventor of this case has made great efforts in research and found that the above-mentioned problems can be solved by using a liquid crystal alignment agent containing specific components, thus completing the present invention.

本發明具體而言具有下列態樣。The present invention specifically has the following aspects.

一種液晶配向劑,其特徵為含有聚合物(A),該聚合物(A)係選自於由具有下式(1)表示之重複單元(a1)之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種。A liquid crystal alignment agent is characterized by containing a polymer (A), wherein the polymer (A) is at least one selected from the group consisting of a polyimide precursor having a repeating unit (a1) represented by the following formula (1) and a polyimide which is an imide compound of the polyimide precursor.

[化1] [Chemistry 1]

R及Z各自獨立地表示氫原子或1價有機基。 又,本說明書全體中,以下之用語及簡稱之含意各為如下。鹵素原子為氟原子、氯原子、溴原子、碘原子等。 *皆代表原子鍵。又,Boc表示第三丁氧基羰基,Fmoc表示9-茀基甲氧基羰基。 (發明之效果) R and Z each independently represent a hydrogen atom or a monovalent organic group. In addition, throughout this specification, the following terms and abbreviations have the following meanings. Halogen atoms are fluorine atoms, chlorine atoms, bromine atoms, iodine atoms, etc. * All represent atomic bonds. In addition, Boc represents tert-butyloxycarbonyl, and Fmoc represents 9-fluorenylmethoxycarbonyl. (Effect of the invention)

依照本發明,可提供可獲得即使是使用經取代之環丁烷四羧酸二酐或其衍生物為原料獲得之聚醯亞胺液晶配向膜仍具高機械強度之液晶配向膜之液晶配向劑、該液晶配向膜、及使用了該液晶配向膜之液晶顯示元件。According to the present invention, a liquid crystal alignment agent can be provided which can obtain a liquid crystal alignment film having high mechanical strength even when a polyimide liquid crystal alignment film is obtained using substituted cyclobutanetetracarboxylic dianhydride or a derivative thereof as a raw material, the liquid crystal alignment film, and a liquid crystal display element using the liquid crystal alignment film.

本發明獲得上述效果之機轉未必明瞭,但是據認為以下所述為其原因之一。據認為取代基越少則立體障礙越小,不妨礙分子間的交互作用,故可獲得上述效果。The mechanism by which the present invention achieves the above effects is not necessarily clear, but the following is considered to be one of the reasons: It is considered that the fewer the substituents, the smaller the steric hindrance, which does not hinder the interaction between molecules, and thus the above effects can be achieved.

<聚合物(A)> 本發明之液晶配向劑,含有係選自於由具有下式(1)表示之重複單元(a1)之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物(A)。又,聚合物(A)可為1種或由2種以上構成。 <Polymer (A)> The liquid crystal alignment agent of the present invention contains at least one polymer (A) selected from the group consisting of a polyimide precursor having a repeating unit (a1) represented by the following formula (1) and a polyimide as an imide compound of the polyimide precursor. In addition, the polymer (A) may be one kind or composed of two or more kinds.

[化2] [Chemistry 2]

R及Z各自獨立地表示氫原子或1價有機基。R and Z each independently represent a hydrogen atom or a monovalent organic group.

上式(1)中,R、Z的1價有機基,例如為碳數1~20之1價烴基、該烴基之亞甲基被-O-、-S-、-CO-、-COO-、-COS-、-NR 3-、-CO-NR 3-、-Si(R 3) 2-(惟R 3為氫原子或碳數1~10之1價烴基,R 3有多個時,各R 3可相同也可不同。)、-SO 2-等取代而成的1價基A、此1價烴基或1價基A之碳原子鍵結之氫原子之至少1個被鹵素原子(氟原子、氯原子、溴原子、碘原子等)、羥基、烷氧基、硝基、胺基、巰基、亞硝基、烷基矽基、烷氧基矽基、矽醇基、亞磺酸基、膦基、羧基、氰基、磺基、醯基等取代而成之1價基、具有雜環之1價基等。上式(1)中,R、Z之1價有機基為碳數1~10之烷基、碳數2~10之烯基、碳數2~10之炔基、Boc、或Fmoc較理想,碳數1~3之烷基更佳,甲基更理想。 In the above formula (1), the monovalent organic group of R and Z is, for example, a monovalent alkyl group having 1 to 20 carbon atoms, the methylene group of the alkyl group being -O-, -S-, -CO-, -COO-, -COS-, -NR 3 -, -CO-NR 3 -, -Si(R 3 ) 2 - (however, R 3 is a hydrogen atom or a monovalent alkyl group having 1 to 10 carbon atoms, and when there are multiple R 3 , each R 3 may be the same or different.), -SO 2 -, a monovalent group A substituted with a halogen atom (fluorine atom, chlorine atom, bromine atom, iodine atom, etc.), a hydroxyl group, an alkoxyl group, a nitro group, an amino group, a nitroso group, an alkylsilyl group, an alkoxysilyl group, a silanol group, a sulfinic acid group, a phosphino group, a carboxyl group, a cyano group, a sulfonic acid group, an acyl group, etc., a monovalent group having a heterocyclic ring, etc. In the above formula (1), the monovalent organic group of R and Z is preferably an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, Boc, or Fmoc, more preferably an alkyl group having 1 to 3 carbon atoms, and more preferably a methyl group.

針對R及Z,考量理想地獲得本發明之效果之觀點,各自獨立地為氫原子或碳數1~3之烷基較理想,氫原子或甲基更理想。From the viewpoint of ideally obtaining the effects of the present invention, R and Z are each independently a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, preferably a hydrogen atom or a methyl group, more preferably.

上述聚合物(A),考量理想地獲得本發明之效果之觀點,也可為選自於由同時具有上式(1)表示之重複單元(a1)及下式(2)表示之重複單元(a2)之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物。又,重複單元(a2)可為1種或也可由2種以上構成。From the viewpoint of obtaining the effects of the present invention in an ideal manner, the polymer (A) may be at least one polymer selected from the group consisting of a polyimide precursor having both a repeating unit (a1) represented by the above formula (1) and a repeating unit (a2) represented by the following formula (2), and a polyimide which is an imide product of the polyimide precursor. The repeating unit (a2) may be one type or may be composed of two or more types.

[化3] [Chemistry 3]

上式(2)中,R、及Z和上式(1)的情形同義。Y 2表示下式(O)表示之2價有機基。 In the above formula (2), R and Z have the same meanings as in the above formula (1). Y2 represents a divalent organic group represented by the following formula (O).

[化4] [Chemistry 4]

上式(O)中,Ar各自獨立地表示苯環、聯苯結構、或萘環。Ar之環上之任意氫原子也可被鹵素原子或1價有機基取代。Q 2表示-(CH 2) n-(n為2~18。)、或此-(CH 2) n-之一部分被-O-、-C(=O)-或-O-C(=O)-中之任一者取代的基。 In the above formula (O), Ar each independently represents a benzene ring, a biphenyl structure, or a naphthalene ring. Any hydrogen atom on the Ar ring may be substituted by a halogen atom or a monovalent organic group. Q2 represents -( CH2 ) n- (n is 2 to 18), or a group in which a part of -( CH2 ) n- is substituted by any one of -O-, -C(=O)-, or -OC(=O)-.

上式(O)中,上述鹵素原子,例如氟原子、氯原子、溴原子、碘原子。上述1價有機基,例如:甲基、乙基、丙基、異丙基等碳數1~3之烷基;乙烯基、丙烯基、丁烯基等碳數2~3之烯基;乙炔基、1-丙炔基、2-丙炔基等碳數2~3之炔基;氟甲基、三氟甲基、五氟乙基、五氟丙基等含氟原子之碳數1~3之1價有機基等。In the above formula (O), the halogen atom is, for example, a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom. The monovalent organic group is, for example, an alkyl group having 1 to 3 carbon atoms, such as methyl, ethyl, propyl, and isopropyl; an alkenyl group having 2 to 3 carbon atoms, such as vinyl, propenyl, and butenyl; an alkynyl group having 2 to 3 carbon atoms, such as ethynyl, 1-propynyl, and 2-propynyl; and a monovalent organic group having 1 to 3 carbon atoms and containing fluorine atoms, such as fluoromethyl, trifluoromethyl, pentafluoroethyl, and pentafluoropropyl.

上式(O)表示之2價有機基,考量提高液晶配向性之觀點,下式(o-1)~(o-15)中之任一者表示之2價有機基為較佳。式(o-10)中,m為2為較佳。(o-14)中,m為0或2更理想。The divalent organic group represented by the above formula (O) is preferably a divalent organic group represented by any one of the following formulas (o-1) to (o-15) from the viewpoint of improving the liquid crystal alignment. In formula (o-10), m is preferably 2. In formula (o-14), m is more preferably 0 or 2.

[化5] [Chemistry 5]

[化6] [Chemistry 6]

式(o-14)~(o-15)中,2個m各自獨立。 上述聚合物(A),考量理想地獲得本發明之效果之觀點,也可為選自於由具有上式(1)表示之重複單元(a1)、或同時具有上述重複單元(a1)及上式(2)表示之重複單元(a2)、及下式(2’)表示之重複單元(a2’)以及下式(3)表示之重複單元(a3)構成之群組中之至少一者之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物。 In formula (o-14) to (o-15), the two m are independent of each other. From the viewpoint of ideally obtaining the effect of the present invention, the above-mentioned polymer (A) may also be at least one polymer selected from the group consisting of a polyimide precursor having a repeating unit (a1) represented by the above formula (1), or having at least one of the above repeating units (a1) and the repeating units (a2) represented by the above formula (2), and repeating units (a2') represented by the following formula (2') and repeating units (a3) represented by the following formula (3), and a polyimide which is an imide compound of the polyimide precursor.

[化7] [Chemistry 7]

上式(2’)及式(3)中,X 2’及X 3表示4價有機基,Y 2’表示下式(O2)表示之2價有機基,Y 3表示分子內具有基「-N(D)-(D表示胺甲酸酯系保護基。)」且排除D之碳數6~30之2價有機基。R、及Z和上式(1)的情形同義。 In the above formula (2') and formula (3), X 2' and X 3 represent a tetravalent organic group, Y 2' represents a divalent organic group represented by the following formula (O2), and Y 3 represents a divalent organic group having a carbon number of 6 to 30 excluding D and having a group "-N(D)-(D represents a carbamate protective group)" in the molecule. R and Z have the same meanings as in the case of the above formula (1).

[化8] [Chemistry 8]

上式(O2)中,m為0~2之整數,Ar 2’表示未經取代或經取代之苯環。惟m為0時,Ar 2’表示未經取代之苯環,m為1~2時,Ar 2’各自獨立地表示未經取代之苯環、或該苯環上之任意氫原子被鹵素原子或1價有機基(例如:碳數1~3之烷基、碳數2~3之烯基、碳數2~3之炔基、含氟原子之碳數1~3之1價有機基等)取代之苯環。Q 2’表示單鍵、或-O-。Ar 2’、Q 2’有多個存在時,各自可相同也可不同。 In the above formula (O2), m is an integer of 0 to 2, and Ar 2' represents an unsubstituted or substituted benzene ring. However, when m is 0, Ar 2' represents an unsubstituted benzene ring, and when m is 1 to 2, Ar 2' each independently represents an unsubstituted benzene ring, or a benzene ring in which any hydrogen atom on the benzene ring is substituted by a halogen atom or a monovalent organic group (for example, an alkyl group having 1 to 3 carbon atoms, an alkenyl group having 2 to 3 carbon atoms, an alkynyl group having 2 to 3 carbon atoms, a monovalent organic group having 1 to 3 carbon atoms and containing a fluorine atom, etc.). Q 2' represents a single bond, or -O-. When multiple Ar 2' and Q 2' exist, they may be the same or different.

上式(O2)表示之2價有機基,考量理想地獲得本發明之效果之觀點,下式(o2-1)~(o2-12)中之任一者表示之2價有機基為較佳。From the viewpoint of ideally obtaining the effect of the present invention, the divalent organic group represented by the above formula (O2) is preferably a divalent organic group represented by any one of the following formulas (o2-1) to (o2-12).

[化9] [Chemistry 9]

上式(3)中,Y 3之D表示胺甲酸酯系保護基,胺甲酸酯系保護基,例如:Boc或Fmoc。上述Y 3之具體例,例如下式(Dx)表示之2價有機基。 In the above formula (3), D of Y 3 represents a carbamate protecting group, and a carbamate protecting group is, for example, Boc or Fmoc. Specific examples of the above Y 3 are, for example, a divalent organic group represented by the following formula (Dx).

[化10] [Chemistry 10]

上式(Dx)中,Q 5為單鍵、-(CH 2) n-(n為1~20)、或該-(CH 2) n-之任意-CH 2-被-O-、-Si(CH 3) 2-、-COO-、-OCO-、-NQ 9-、-NQ 9-CO-、-CO-NQ 9-、-NQ 9-CO-NQ 10-、-NQ 9-COO-或-O-COO-取代之基,Q 9及Q 10各自獨立地表示氫原子或1價有機基。 In the above formula (Dx), Q5 is a single bond, -( CH2 ) n- (n is 1 to 20), or a group in which any -CH2- of the -( CH2 ) n- is substituted by -O-, -Si( CH3 ) 2- , -COO-, -OCO-, -NQ9- , -NQ9- CO- , -CO- NQ9- , -NQ9 -CO- NQ10- , -NQ9- COO- or -O-COO-, and Q9 and Q10 each independently represent a hydrogen atom or a monovalent organic group.

Q 6及Q 7各自獨立地表示-H、-NHD、-N(D) 2、具有-NHD之基、或具有-N(D) 2之基。惟m=0時,Q 6具有胺甲酸酯系保護基,m=1時,Q 5、Q 6及Q 7中之至少一個於基中具有胺甲酸酯系保護基。又,Q 6、Q 7中,表示具有-NHD之基、或具有-N(D) 2之基時,D以外的Q 6、Q 7之理想碳數為1~10,更佳為1~8。 Q 6 and Q 7 each independently represent -H, -NHD, -N(D) 2 , a group having -NHD, or a group having -N(D) 2. However, when m=0, Q 6 has a carbamate-based protecting group, and when m=1, at least one of Q 5 , Q 6 and Q 7 has a carbamate-based protecting group in the group. Furthermore, when Q 6 and Q 7 represent a group having -NHD or a group having -N(D) 2 , the number of carbon atoms of Q 6 and Q 7 other than D is preferably 1 to 10, more preferably 1 to 8.

上述Q 9及Q 10之1價有機基,例如碳數1~3之烷基、碳數2~3之烯基、碳數2~3之炔基、含氟原子之碳數1~3之1價有機基、Boc或Fmoc。碳數1~3之烷基、碳數2~3之烯基、碳數2~3之炔基、含氟原子之碳數1~3之1價有機基之具體例,例如和上式(O)例示之1價有機基為同樣的結構。 The monovalent organic group of Q9 and Q10 is, for example, an alkyl group having 1 to 3 carbon atoms, an alkenyl group having 2 to 3 carbon atoms, an alkynyl group having 2 to 3 carbon atoms, a monovalent organic group having 1 to 3 carbon atoms containing a fluorine atom, Boc or Fmoc. Specific examples of the alkyl group having 1 to 3 carbon atoms, the alkenyl group having 2 to 3 carbon atoms, the alkynyl group having 2 to 3 carbon atoms, and the monovalent organic group having 1 to 3 carbon atoms containing a fluorine atom are, for example, the same structures as the monovalent organic group exemplified in the above formula (O).

Y 3之理想具體例,考量理想地獲得本發明之效果之觀點,例如下式(Y3-1)~(Y3-9)中之任一者表示之2價有機基。 A preferred specific example of Y3 is a divalent organic group represented by any one of the following formulae (Y3-1) to (Y3-9), from the viewpoint of ideally obtaining the effects of the present invention.

[化11] [Chemistry 11]

上式(2’)、式(3)中之X 2’、X 3,例如下式(g)表示之4價有機基,此外,例如下式(X-1)~(X-25)中之任一者表示之4價有機基、來自芳香族四羧酸二酐之4價有機基等。考量理想地獲得本發明之效果之觀點,X 2’及X 3為下式(g)表示之4價有機基更佳,又更佳為R 1及R 4係甲基且R 2及R 3係氫原子的(g)表示之4價有機基。 X 2' and X 3 in the above formula (2') and formula (3) are, for example, a quaternary organic group represented by the following formula (g), a quaternary organic group represented by any one of the following formulas (X-1) to (X-25), a quaternary organic group derived from an aromatic tetracarboxylic dianhydride, etc. From the viewpoint of ideally obtaining the effect of the present invention, X 2' and X 3 are preferably quaternary organic groups represented by the following formula (g), and more preferably, a quaternary organic group represented by (g) in which R 1 and R 4 are methyl groups and R 2 and R 3 are hydrogen atoms.

[化12] [Chemistry 12]

R 1~R 4各自獨立地表示氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含氟原子之碳數1~6之1價有機基、或苯基,R 1~R 4中之至少一者表示上述定義中之氫原子以外之基。 R 1 to R 4 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having 1 to 6 carbon atoms containing a fluorine atom, or a phenyl group, and at least one of R 1 to R 4 represents a group other than a hydrogen atom in the above definition.

[化13] [Chemistry 13]

[化14] [Chemistry 14]

上式(g)之R 1~R 4中,碳數1~6之烷基之具體例,例如甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、正戊基等。上述R 1~R 4中,碳數2~6之烯基之具體例例如乙烯基、丙烯基、丁烯基等,它們可為直鏈狀也可為分支狀。上述R 1~R 4中之碳數2~6之炔基之具體例,例如乙炔基、1-丙炔基、2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基等。上述R 1~R 4中,含氟原子之碳數1~6之1價有機基,例如氟甲基、三氟甲基、五氟乙基、五氟丙基等。 In the above formula (g), specific examples of alkyl groups having 1 to 6 carbon atoms include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, etc. Specific examples of alkenyl groups having 2 to 6 carbon atoms in the above R 1 to R 4 include vinyl, propenyl, butenyl, etc., which may be linear or branched. Specific examples of alkynyl groups having 2 to 6 carbon atoms in the above R 1 to R 4 include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, etc. Specific examples of monovalent organic groups having 1 to 6 carbon atoms and containing fluorine atoms in the above R 1 to R 4 include fluoromethyl, trifluoromethyl, pentafluoroethyl, pentafluoropropyl, etc.

上述芳香族四羧酸二酐,係藉由鍵結在苯環、萘環等芳香環之羧基進行分子內脫水而獲得之酸二酐。若舉具體例,例如下式(Xa-1)~(Xa-2)中之任一者表示之4價有機基、下式(Xr-1)~(Xr-7)中之任一者表示之4價有機基。The aromatic tetracarboxylic dianhydride is an acid dianhydride obtained by dehydrating the carboxyl group of an aromatic ring such as a benzene ring or a naphthalene ring through the molecular structure. For example, a tetravalent organic group represented by any one of the following formulas (Xa-1) to (Xa-2) or a tetravalent organic group represented by any one of the following formulas (Xr-1) to (Xr-7).

[化15] [Chemistry 15]

x及y各自獨立地為單鍵、醚、羰基、酯、碳數1~10之烷二基、1,4-伸苯基、磺醯基或醯胺鍵。j及k為0或1。x and y are each independently a single bond, an ether, a carbonyl group, an ester, an alkanediyl group having 1 to 10 carbon atoms, a 1,4-phenylene group, a sulfonyl group, or an amide bond. j and k are 0 or 1.

[化16] [Chemistry 16]

上式(Xa-1)或(Xa-2)表示之4價有機基,也可為下式(Xa-3)~(Xa-19)中之任一者表示之結構。The tetravalent organic group represented by the above formula (Xa-1) or (Xa-2) may also be a structure represented by any one of the following formulas (Xa-3) to (Xa-19).

[化17] [Chemistry 17]

[化18] [Chemistry 18]

上述聚合物(A),也可為選自於由具有上述重複單元(a1)、重複單元(a2)、重複單元(a2’)、重複單元(a3)以外更具有下式(4)表示之重複單元(a4)之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物。The polymer (A) may be at least one polymer selected from the group consisting of a polyimide precursor having a repeating unit (a4) represented by the following formula (4) in addition to the repeating unit (a1), repeating unit (a2), repeating unit (a2′), and repeating unit (a3), and a polyimide which is an imide product of the polyimide precursor.

[化19] [Chemistry 19]

上式(4)中,X 4表示4價有機基,Y 4表示2價有機基。R、Z各和上式(1)之R、Z同義。惟Y 4表示分子內具有基「-N(D)-(D表示胺甲酸酯系保護基。)」且排除D之碳數6~30之2價有機基及上式(O2)表示之2價有機基以外之結構。又,當和X 4為上式(g)表示之4價有機基,R 1及R 4為甲基,且R 2及R 3為氫原子之4價有機基同義時,Y 4表示2-甲基-1,4-伸苯基、及上式(O)表示之2價有機基以外之結構。 In the above formula (4), X4 represents a quaternary organic group, and Y4 represents a divalent organic group. R and Z are the same as R and Z in the above formula (1). However, Y4 represents a structure having a group "-N(D)-(D represents a carbamate-based protective group)" in the molecule, and excluding a divalent organic group having 6 to 30 carbon atoms in D and a divalent organic group represented by the above formula (O2). In addition, when X4 is a quaternary organic group represented by the above formula (g), R1 and R4 are methyl groups, and R2 and R3 are hydrogen atoms, Y4 represents a structure other than 2-methyl-1,4-phenylene and a divalent organic group represented by the above formula (O).

X 4之具體例,例如上述X 2’例示之4價有機基。考量理想地獲得本發明之效果之觀點,X 4為上式(g)表示之4價有機基、或上式(X-1)~(X-25)中之任一者表示之4價有機基較理想,上式(g)表示之4價有機基更佳。 Specific examples of X4 include the tetravalent organic groups exemplified above as X2 ' . From the perspective of ideally achieving the effects of the present invention, X4 is preferably a tetravalent organic group represented by the above formula (g) or a tetravalent organic group represented by any one of the above formulas (X-1) to (X-25), and a tetravalent organic group represented by the above formula (g) is more preferred.

Y 4之2價有機基之具體例,例如上式(O)例示之2價有機基,此外,例如來自以下記載之二胺之2價有機基(從二胺取走2個胺基之2價有機基)。 Specific examples of the divalent organic group for Y4 include the divalent organic groups exemplified in the above formula (O) and, for example, the divalent organic group derived from the diamine described below (a divalent organic group obtained by removing two amino groups from a diamine).

來自2,5-二甲基-1,4-苯二胺、2-氟-1,4-苯二胺、2-甲氧基-1,4-苯二胺、2,5-二甲氧基-1,4-苯二胺、4,4’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、3,3’-二甲基-4,4’-二胺基二苯基甲烷;下式(g-1)~(g-9)表示之二胺等具有光配向性基之二胺;下式(u-1)~(u-3)表示之二胺等具有脲鍵之二胺(惟該二胺在分子內沒有胺甲酸酯系保護基。);下式(u-4)~(u-7)表示之二胺等具有醯胺鍵之二胺(惟該二胺在分子內沒有胺甲酸酯系保護基。);具有選自於由含氮原子之雜環、二級胺基及三級胺基構成之群組中之至少一種含氮原子之結構(以下也稱為含氮原子之結構。惟上述二級胺基及三級胺基中,該胺基未鍵結在胺甲酸酯系保護基。)之二胺;2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚;2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸或下式(3b-1)~式(3b-4)表示之二胺化合物等具有羧基之二胺;4-(2-(甲胺基)乙基)苯胺、4-(2-胺基乙基)苯胺、4,4’-二胺基二苯基酮、1-(4-胺基苯基)-1,3,3-三甲基-1H-二氫茚-5-胺、1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺;甲基丙烯酸2-(2,4-二胺基苯氧基)乙酯、2,4-二胺基-N,N-二烯丙基苯胺等末端具有光聚合性基之二胺;膽甾烷基氧基-3,5-二胺基苯、膽甾烯基氧基-3,5-二胺基苯、膽甾烷基氧基-2,4-二胺基苯、3,5-二胺基苯甲酸膽甾烷酯、3,5-二胺基苯甲酸膽甾烯酯、3,5-二胺基苯甲酸羊毛甾烷酯及3,6-雙(4-胺基苯甲醯氧基)膽甾烷等具有類固醇骨架之二胺;下式(V-1)~(V-6)表示之二胺;1,3-雙(3-胺基丙基)-四甲基二矽氧烷等具有矽氧烷鍵之二胺;下式(Ox-1)、(Ox-2)等具有㗁唑啉環結構之二胺; 1-(4-(2-(2,4-二胺基苯氧基)乙氧基)苯基)-2-羥基-2-甲基丙酮、2-(4-(2-羥基-2-甲基丙醯基)苯氧基)乙基-3,5-二胺基苯甲酸酯、4,4’-二胺基二苯基酮、3,3’-二胺基二苯基酮等具有自由基聚合起始劑作用之二胺等二胺之2價有機基、WO2018/117239號公報記載之式(Y-1)~(Y-167)中之任一者表示之基。2,5-dimethyl-1,4-phenylenediamine, 2-fluoro-1,4-phenylenediamine, 2-methoxy-1,4-phenylenediamine, 2,5-dimethoxy-1,4-phenylenediamine, 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminodiphenylmethane; diamines having a photo-alignment group such as diamines represented by the following formulas (g-1) to (g-9); diamines having a urea bond such as diamines represented by the following formulas (u-1) to (u-3) (however, the diamines do not have a carbamate protective group in the molecule); diamines represented by the following formulas (u-4) to (u-7) diamines having an amide bond, such as the diamines shown in the figure (but the diamines do not have a carbamate-based protective group in the molecule); diamines having at least one nitrogen-containing structure selected from the group consisting of a nitrogen-containing heterocycle, a diamine group, and a tertiary amine group (hereinafter also referred to as a nitrogen-containing structure. However, in the above-mentioned diamine groups and tertiary amine groups, the amine groups are not bonded to a carbamate-based protective group); 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol; 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5- Diamines having a carboxyl group, such as diaminobenzoic acid or diamine compounds represented by the following formula (3b-1) to (3b-4); 4-(2-(methylamino)ethyl)aniline, 4-(2-aminoethyl)aniline, 4,4'-diaminodiphenyl ketone, 1-(4-aminophenyl)-1,3,3-trimethyl-1H-dihydroindene-5-amine, 1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-indene-6-amine; diamines having a photopolymerizable group at the end, such as 2-(2,4-diaminophenoxy)ethyl methacrylate and 2,4-diamino-N,N-diallylaniline ; diamines having a steroid skeleton such as cholestanyloxy-3,5-diaminobenzene, cholestanyloxy-3,5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, 3,5-diaminobenzoic acid cholestanyl ester, 3,5-diaminobenzoic acid cholestanyl ester, 3,5-diaminobenzoic acid lanostanyl ester and 3,6-bis(4-aminobenzyloxy)cholestane; diamines represented by the following formulas (V-1) to (V-6); diamines having a siloxane bond such as 1,3-bis(3-aminopropyl)-tetramethyldisiloxane; diamines having an oxazoline ring structure such as the following formulas (Ox-1) and (Ox-2); A divalent organic group of a diamine such as a diamine having a free radical polymerization initiator function, such as 1-(4-(2-(2,4-diaminophenoxy)ethoxy)phenyl)-2-hydroxy-2-methylacetone, 2-(4-(2-hydroxy-2-methylpropionyl)phenoxy)ethyl-3,5-diaminobenzoate, 4,4'-diaminodiphenyl ketone, 3,3'-diaminodiphenyl ketone, or a group represented by any one of formulas (Y-1) to (Y-167) described in WO2018/117239.

[化20] [Chemistry 20]

[化21] [Chemistry 21]

[化22] [Chemistry 22]

上式(3b-1)中,A 1表示單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-,m1及m2各自獨立地表示0~4,且m1及m2之合計為1~4。 In the above formula (3b-1), A1 represents a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2- , -C( CF3 ) 2- , -O-, -CO-, -NH-, -N( CH3 )-, -CONH-, -NHCO-, -CH2O-, -OCH2- , -COO- , -OCO-, -CON( CH3 )- or -N( CH3 )CO-, m1 and m2 each independently represent 0 to 4, and the total of m1 and m2 is 1 to 4.

上式(3b-2)中,m3及m4各自獨立地表示1~5。上式(3b-3)中,A 2表示碳數1~5之直鏈或分支烷基,m5為1~5。上式(3b-4)中,A 3及A 4各自獨立地表示單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)-CO-,m6為1~4。 In the above formula (3b-2), m3 and m4 each independently represent 1 to 5. In the above formula (3b-3), A2 represents a linear or branched alkyl group having 1 to 5 carbon atoms, and m5 is 1 to 5. In the above formula (3b- 4 ), A3 and A4 each independently represent a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2- , -C( CF3 ) 2- , -O-, -CO-, -NH-, -N( CH3 )-, -CONH-, -NHCO-, -CH2O- , -OCH2- , -COO-, -OCO-, -CON( CH3 )- or -N( CH3 )-CO-, and m6 is 1 to 4.

[化23] [Chemistry 23]

上式(V-1)~(V-6)中,X v1~X v4、X p1~X p2各自獨立地表示-(CH 2) a-(a為1~15。)、-CONH-、-NHCO-、-CON(CH 3)-、-NH-、-O-、-CH 2O-、-CH 2OCO-、-COO-、或-OCO-,X v5表示-O-、-CH 2O-、-CH 2OCO-、-COO-、或-OCO-。X a表示單鍵、-O-、-NH-、-O-(CH 2) m-O-(m為1~6。)、-C(CH 3) 2-、-CO-、-(CH 2) m-(m為1~6。)、-SO 2-、-O-C(CH 3) 2-、-CO-(CH 2) m-(m為1~6。)、-NH-(CH 2) m-(m為1~6。)、-SO 2-(CH 2) m-(m表示1~6。)、-CONH-(CH 2) m-(m為1~6。)、-CONH-(CH 2) m-NHCO-(m為1~6。)、-COO-(CH 2) m-OCO-(m為1~6。)、-CONH-、-NH-(CH 2) m-NH-(m表示1~6。)、或-SO 2-(CH 2) m-SO 2-(m為1~6。),R v1~R v4、R 1a~R 1b各自獨立地表示碳數1~20之烷基、碳數1~20之烷氧基或碳數2~20之烷氧基烷基。k各自可相同也可不同。 In the above formulae (V-1) to (V-6), Xv1 to Xv4 and Xp1 to Xp2 each independently represent -( CH2 ) a- (a is 1 to 15), -CONH-, -NHCO-, -CON( CH3 )-, -NH-, -O- , -CH2O- , -CH2OCO-, -COO-, or -OCO-, and Xv5 represents -O- , -CH2O- , -CH2OCO-, -COO-, or -OCO-. Xa represents a single bond, -O-, -NH-, -O-( CH2 ) m -O- (m is 1 to 6), -C( CH3 ) 2- , -CO-, -( CH2 ) m- (m is 1 to 6), -SO2- , -OC( CH3 ) 2- , -CO-( CH2 ) m- (m is 1 to 6), -NH-( CH2 ) m- (m is 1 to 6), -SO2- ( CH2 ) m- (m is 1 to 6), -CONH-( CH2 ) m- (m is 1 to 6), -CONH-( CH2 ) m -NHCO- (m is 1 to 6), -COO-( CH2 ) m -OCO- (m is 1 to 6), -CONH-, -NH-( CH2 ) m -NH- (m is 1 to 6), or -SO2- ( CH2 ) m - SO2- (m is 1 to 6), Rv1 to Rv4 and R1a to R1b each independently represent an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms or an alkoxyalkyl group having 2 to 20 carbon atoms. k may be the same or different.

[化24] [Chemistry 24]

上述含氮原子之雜環,例如:吡咯、咪唑、吡唑、三唑、吡啶、嘧啶、嗒𠯤、吡𠯤、吲哚、苯并咪唑、嘌呤、喹啉、異喹啉、㖠啶、喹㗁啉、酞𠯤、三𠯤、咔唑、吖啶、哌啶、哌𠯤、吡咯啶、六亞甲基亞胺等。其中,吡啶、嘧啶、吡𠯤、哌啶、哌𠯤、喹啉、咔唑或吖啶為較佳。The above-mentioned nitrogen-containing heterocyclic ring includes, for example, pyrrole, imidazole, pyrazole, triazole, pyridine, pyrimidine, phthalimide, pyrrolidine, indole, benzimidazole, purine, quinoline, isoquinoline, oxadiazole, quinoline, phthalimide, triazole, carbazole, acridine, piperidine, piperidine, pyrrolidine, hexamethyleneimine, etc. Among them, pyridine, pyrimidine, pyrrolidine, piperidine, piperidine, quinoline, carbazole or acridine is preferred.

具有含氮原子之結構之二胺也可擁有之二級胺基及三級胺基,例如以下式(n)表示。The diamine having a structure containing a nitrogen atom may also have a secondary amine group and a tertiary amine group, which are represented by the following formula (n), for example.

[化25] [Chemistry 25]

上式(n)中,R表示氫原子或碳數1~10之1價烴基。「*1」表示鍵結在烴基的原子鍵。上式(n)中之R之1價烴基,例如:甲基、乙基、丙基等烷基;環己基等環烷基;苯基、甲基苯基等芳基等。R較佳為氫原子或甲基。In the above formula (n), R represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms. "*1" represents an atomic bond to the hydrocarbon group. The monovalent hydrocarbon group of R in the above formula (n) is, for example, an alkyl group such as methyl, ethyl, propyl, etc.; a cycloalkyl group such as cyclohexyl, etc.; an aryl group such as phenyl, methylphenyl, etc. R is preferably a hydrogen atom or a methyl group.

具有含氮原子之結構之二胺之具體例,例如:2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)-哌𠯤、3,6-二胺基吖啶、下式(Dp-1)~(Dp-8)表示之化合物、或下式(z-1)~式(z-13)表示之化合物。Specific examples of diamines having a structure containing a nitrogen atom include 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, 1,4-bis-(4-aminophenyl)-piperidinium, 3,6-diaminoacridine, compounds represented by the following formulas (Dp-1) to (Dp-8), or compounds represented by the following formulas (z-1) to (z-13).

[化26] [Chemistry 26]

[化27] [Chemistry 27]

[化28] [Chemistry 28]

考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a1)及該重複單元(a1)之醯亞胺化結構單元之合計含量為全部重複單元之10~100莫耳%較佳,15~100莫耳%更佳。又,在此之合計,也包括重複單元(a1)及重複單元(a1)之醯亞胺化結構單元中任一者為0莫耳%的情形。以下,指稱合計時,也包括構成單元要素之1或2種以上為0莫耳%的情形。From the viewpoint of ideally obtaining the effect of the present invention, in the polymer (A), the total content of the repeating unit (a1) and the imidized structural unit of the repeating unit (a1) is preferably 10 to 100 mol% of all the repeating units, and more preferably 15 to 100 mol%. In addition, the total here also includes the case where either the repeating unit (a1) or the imidized structural unit of the repeating unit (a1) is 0 mol%. Hereinafter, when referring to the total, it also includes the case where one or more of the constituent unit elements are 0 mol%.

聚合物(A)含有重複單元(a1)及重複單元(a1)之醯亞胺化結構單元以外之重複單元時,前述重複單元(a1)及前述重複單元(a1)之醯亞胺化結構單元之合計含量為全部重複單元之10~95莫耳%較佳。聚合物(A)中,重複單元(a1)及重複單元(a1)之醯亞胺化結構單元之合計含量為全部重複單元之95莫耳%以下較佳,90莫耳%以下更佳,80莫耳%以下更理想。又,聚合物(A)中,重複單元(a1)及重複單元(a1)之醯亞胺化結構單元之合計含量為全部重複單元之10莫耳%以上較佳,15莫耳%以上較佳。When the polymer (A) contains repeating units other than the imidized structural units of the repeating units (a1) and the repeating units (a1), the total content of the repeating units (a1) and the imidized structural units of the repeating units (a1) is preferably 10 to 95 mol% of the total repeating units. In the polymer (A), the total content of the repeating units (a1) and the imidized structural units of the repeating units (a1) is preferably 95 mol% or less, more preferably 90 mol% or less, and more preferably 80 mol% or less of the total repeating units. In addition, in the polymer (A), the total content of the repeating units (a1) and the imidized structural units of the repeating units (a1) is preferably 10 mol% or more, and more preferably 15 mol% or more of the total repeating units.

考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a2)及重複單元(a2)之醯亞胺化結構單元之合計含量為全部重複單元之5莫耳%以上較佳,10莫耳%以上更佳,20莫耳%以上更佳,另一方面,90莫耳%以下較佳,85莫耳%以下更佳。又,考量理想地獲得本發明之效果之觀點,前述聚合物(A)中,前述重複單元(a2)及前述重複單元(a2)之醯亞胺化結構單元之合計含量為全部重複單元之10~90莫耳%較佳。From the viewpoint of ideally obtaining the effect of the present invention, in the polymer (A), the total content of the repeating unit (a2) and the imidized structural unit of the repeating unit (a2) is preferably 5 mol% or more, more preferably 10 mol% or more, more preferably 20 mol% or more of the total repeating units, and on the other hand, it is preferably 90 mol% or less, and more preferably 85 mol% or less. In addition, from the viewpoint of ideally obtaining the effect of the present invention, in the aforementioned polymer (A), the total content of the aforementioned repeating unit (a2) and the imidized structural unit of the aforementioned repeating unit (a2) is preferably 10-90 mol% of the total repeating units.

考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a1)、重複單元(a2)、及它們的醯亞胺化結構單元之合計含量為全部重複單元之10莫耳%以上較佳,20莫耳%以上更佳。含有重複單元(a1)、重複單元(a2)、及它們的醯亞胺化結構以外之重複單元時,重複單元(a1)、重複單元(a2)、及它們的醯亞胺化結構單元之合計含量為95莫耳%以下較佳,90莫耳%以下更理想。From the viewpoint of ideally obtaining the effects of the present invention, in polymer (A), the total content of repeating units (a1), repeating units (a2), and their imidized structural units is preferably 10 mol% or more of all repeating units, and more preferably 20 mol% or more. When repeating units other than repeating units (a1), repeating units (a2), and their imidized structural units are contained, the total content of repeating units (a1), repeating units (a2), and their imidized structural units is preferably 95 mol% or less, and more preferably 90 mol% or less.

聚合物(A)含有重複單元(a2’)及重複單元(a2’)之醯亞胺化結構單元中之至少任一者時,考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a2’)及重複單元(a2’)之醯亞胺化結構單元之合計含量為全部重複單元之1~50莫耳%較佳,1~40莫耳%更佳,1~30莫耳%更理想。聚合物(A)含有重複單元(a1)及其醯亞胺化結構單元之至少任一者並含有重複單元(a2)及其醯亞胺化結構單元中之至少任一者時,重複單元(a2’)及重複單元(a2’)之醯亞胺化結構單元之之合計含量為5莫耳%以上較佳,10莫耳%以上更理想。When the polymer (A) contains at least one of the repeating unit (a2') and the imidized structural unit of the repeating unit (a2'), from the viewpoint of ideally obtaining the effect of the present invention, the total content of the repeating unit (a2') and the imidized structural unit of the repeating unit (a2') in the polymer (A) is preferably 1 to 50 mol %, more preferably 1 to 40 mol %, and even more preferably 1 to 30 mol % of all the repeating units. When the polymer (A) contains at least one of the repeating unit (a1) and its imidized structural unit and contains at least one of the repeating unit (a2) and its imidized structural unit, the total content of the repeating unit (a2') and the imidized structural unit of the repeating unit (a2') is preferably 5 mol% or more, and more preferably 10 mol% or more.

聚合物(A),考量理想地獲得本發明之效果之觀點,含有重複單元(a1)及其醯亞胺化結構單元中之至少任一者、重複單元(a2)及其醯亞胺化結構中之至少任一者、以及重複單元(a2’)及其醯亞胺化結構單元中之至少任一者,且重複單元(a1)、重複單元(a2)、重複單元(a2’)、及它們的醯亞胺化結構單元之合計含量為全部重複單元之30莫耳%以上較佳,40莫耳%以上更佳。聚合物(A)含有重複單元(a1)、重複單元(a2)、重複單元(a2’)、及它們的醯亞胺化結構單元以外之重複單元時,重複單元(a1)、重複單元(a2)、重複單元(a2’)、及它們的醯亞胺化結構單元之合計含量為95莫耳%以下較佳,90莫耳%以下更理想。From the viewpoint of ideally obtaining the effect of the present invention, the polymer (A) contains at least one of the repeating unit (a1) and its imidized structural unit, at least one of the repeating unit (a2) and its imidized structural unit, and at least one of the repeating unit (a2′) and its imidized structural unit, and the total content of the repeating unit (a1), the repeating unit (a2), the repeating unit (a2′), and their imidized structural units is preferably 30 mol% or more, and more preferably 40 mol% or more, of all the repeating units. When the polymer (A) contains repeating units (a1), repeating units (a2), repeating units (a2'), and repeating units other than imide structural units thereof, the total content of repeating units (a1), repeating units (a2), repeating units (a2'), and their imide structural units is preferably 95 mol % or less, and more preferably 90 mol % or less.

聚合物(A)含有重複單元(a3)及重複單元(a3)之醯亞胺化結構單元中之至少任一者時,考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a3)及重複單元(a3)之醯亞胺化結構之合計含量為全部重複單元之1~40莫耳%較佳,1~30莫耳%更佳,1~25莫耳%更理想。When the polymer (A) contains at least one of the repeating unit (a3) and the imidized structure unit of the repeating unit (a3), from the viewpoint of ideally obtaining the effect of the present invention, the total content of the repeating unit (a3) and the imidized structure unit of the repeating unit (a3) in the polymer (A) is preferably 1 to 40 mol %, more preferably 1 to 30 mol %, and even more preferably 1 to 25 mol % of all the repeating units.

聚合物(A)也可含有重複單元(a2’)、重複單元(a3)、及它們的醯亞胺化結構單元。The polymer (A) may also contain repeating units (a2'), repeating units (a3), and imidized structural units thereof.

聚合物(A)含有上述重複單元(a4)及其醯亞胺化結構單元中之至少任一者時,考量理想地獲得本發明之效果之觀點,由Y 4係沒有碳數4以上之側鏈結構之2價有機基的重複單元(a4)及其醯亞胺化結構單元中之至少任一者構成較佳。 When the polymer (A) contains at least any one of the above-mentioned repeating units (a4) and their imidized structural units, it is preferably composed of at least any one of the repeating units (a4) and their imidized structural units in which Y4 is a divalent organic group having no side chain structure with more than 4 carbon atoms, from the viewpoint of ideally obtaining the effect of the present invention.

上述沒有碳數4以上之側鏈結構之2價有機基,例如來自由從上述其他二胺排除了甲基丙烯酸2-(2,4-二胺基苯氧基)乙酯、2,4-二胺基-N,N-二烯丙基苯胺、上述具有類固醇骨架之二胺、上式(V-1)~(V-6)表示之二胺、1-(4-(2,4-二胺基苯氧基)乙氧基)苯基)-2-羥基-2-甲基丙酮、2-(4-(2-羥基-2-甲基丙醯基)苯氧基)乙基-3,5-二胺基苯甲酸酯、N-苯基-3,6-二胺基咔唑、(z-4)及(z-6)表示之二胺等之二胺構成之群組中選出之二胺之2價有機基。The above-mentioned divalent organic group having no side chain structure with more than 4 carbon atoms is, for example, a divalent organic group of a diamine selected from the group consisting of the above-mentioned other diamines excluding 2-(2,4-diaminophenoxy)ethyl methacrylate, 2,4-diamino-N,N-diallylaniline, the above-mentioned diamine having a steroid skeleton, the diamine represented by the above formula (V-1) to (V-6), 1-(4-(2,4-diaminophenoxy)ethoxy)phenyl)-2-hydroxy-2-methylacetone, 2-(4-(2-hydroxy-2-methylpropionyl)phenoxy)ethyl-3,5-diaminobenzoate, N-phenyl-3,6-diaminocarbazole, and the diamine represented by (z-4) and (z-6).

聚合物(A)含有重複單元(a4)及重複單元(a4)之醯亞胺化結構單元中之至少任一者時,考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a4)及重複單元(a4)之醯亞胺化結構之合計含量為全部重複單元之1~90莫耳%較佳,5~70莫耳%更佳,10~30莫耳%更理想。 聚合物(A),考量理想地獲得本發明之效果之觀點,具有R 1及R 4為甲基且R 2及R 3為氫原子之上式(g)表示之4價有機基之重複單元之合計含量,為聚合物(A)擁有之具有來自四羧酸二酐或其衍生物之4價有機基之全部重複單元之50莫耳%以上更佳,80莫耳%以上更佳,100莫耳%最理想。 <聚合物(B)> 本發明之液晶配向劑,除了上述聚合物(A)以外,也可含有分子內沒有上述重複單元(a1)之聚合物(B)。又,聚合物(B)可為1種或由2種以上構成。考量理想地獲得本發明之效果之觀點,聚合物(B)例如具有選自於由下式(5)表示之重複單元(b1)及該重複單元(b1)之醯亞胺化結構單元構成之群組中之至少1種重複單元之聚合物,具有下式(5)表示之重複單元(b1)之聚醯胺酸更理想。又,構成聚合物(B)之重複單元可為1種或由2種以上構成。 When the polymer (A) contains at least one of the repeating unit (a4) and the imidized structure unit of the repeating unit (a4), from the viewpoint of ideally obtaining the effect of the present invention, the total content of the repeating unit (a4) and the imidized structure unit of the repeating unit (a4) in the polymer (A) is preferably 1 to 90 mol %, more preferably 5 to 70 mol %, and even more preferably 10 to 30 mol % of all the repeating units. In order to ideally obtain the effect of the present invention, the total content of repeating units of the above formula (g) having a quaternary organic group in which R1 and R4 are methyl groups and R2 and R3 are hydrogen atoms in the polymer (A) is preferably 50 mol% or more, more preferably 80 mol% or more, and most preferably 100 mol% of all repeating units having a quaternary organic group derived from tetracarboxylic dianhydride or its derivatives possessed by the polymer (A). <Polymer (B)> The liquid crystal alignment agent of the present invention may contain, in addition to the above polymer (A), a polymer (B) having no repeating unit (a1) in the molecule. In addition, the polymer (B) may be one kind or composed of two or more kinds. From the viewpoint of ideally obtaining the effects of the present invention, the polymer (B) is, for example, a polymer having at least one repeating unit selected from the group consisting of a repeating unit (b1) represented by the following formula (5) and an imidized structural unit of the repeating unit (b1), and more preferably a polyamide having a repeating unit (b1) represented by the following formula (5). The repeating unit constituting the polymer (B) may be one type or may be composed of two or more types.

[化29] [Chemistry 29]

上式(5)中,X 5為4價有機基,Y 5為2價有機基。R、Z各和上式(1)之R、Z為同義。 In the above formula (5), X5 is a tetravalent organic group, and Y5 is a divalent organic group. R and Z have the same meanings as R and Z in the above formula (1).

上述X 5之4價有機基,例如來自脂肪族四羧酸二酐之4價有機基、來自脂環族四羧酸二酐之4價有機基或來自芳香族四羧酸二酐之4價有機基,具體例例如上述X 4例示之4價有機基。考量獲得本發明之效果之觀點,上述脂肪族或脂環族四羧酸二酐,其中又以提高液晶配向性之觀點,具有選自於由環丁烷環結構、環戊烷環結構及環己烷環結構構成之群組中之至少一種次結構之四羧酸二酐為較佳。更理想的X 5,為上式(g)表示之4價有機基、上式(X-1)~(X-25)中之任一者表示之4價有機基、上式(Xa-1)~(Xa-2)表示之4價有機基、或上式(Xr-1)~(Xr-7)表示之4價有機基(它們也總稱為特定4價有機基。)。 The tetravalent organic group of X 5 is, for example, a tetravalent organic group derived from aliphatic tetracarboxylic dianhydride, a tetravalent organic group derived from alicyclic tetracarboxylic dianhydride, or a tetravalent organic group derived from aromatic tetracarboxylic dianhydride, and a specific example is the tetravalent organic group exemplified above for X 4. In view of obtaining the effect of the present invention, the aliphatic or alicyclic tetracarboxylic dianhydride is preferably a tetracarboxylic dianhydride having at least one substructure selected from the group consisting of a cyclobutane ring structure, a cyclopentane ring structure, and a cyclohexane ring structure from the viewpoint of improving the alignment of liquid crystals. More preferably, X 5 is a tetravalent organic group represented by the above formula (g), a tetravalent organic group represented by any of the above formulas (X-1) to (X-25), a tetravalent organic group represented by the above formulas (Xa-1) to (Xa-2), or a tetravalent organic group represented by the above formulas (Xr-1) to (Xr-7) (these are also collectively referred to as specific tetravalent organic groups).

聚合物(B),考量獲得本發明之效果之觀點,X 5為上述特定4價有機基之重複單元含量為聚合物(B)中含有的全部重複單元之5莫耳%以上較佳,10莫耳%以上更佳。 In polymer (B), from the viewpoint of obtaining the effect of the present invention, the content of repeating units in which X5 is the above-mentioned specific tetravalent organic group is preferably 5 mol% or more, and more preferably 10 mol% or more of all repeating units contained in polymer (B).

上述Y 5之2價有機基,例如上述Y 4例示之2價有機基。考量來自殘留DC之殘影少的觀點,聚合物(B)為含有Y 5係來自上述具有脲鍵之二胺、上述具有醯胺鍵之二胺、上述具有含氮原子之結構之二胺、2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚、上述具有羧基之二胺、4,4’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、3,3’-二甲基-4,4’-二胺基二苯基甲烷、對苯二胺、或間苯二胺之2價有機基(它們也總稱為特定2價有機基。)之重複單元之聚合物較佳。 The divalent organic group of Y 5 is, for example, the divalent organic group exemplified above for Y 4. From the viewpoint of less residual DC residue, the polymer (B) is preferably a polymer containing repeating units of a divalent organic group wherein Y 5 is derived from the diamine having a urea bond, the diamine having an amide bond, the diamine having a structure containing a nitrogen atom, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, the diamine having a carboxyl group, 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminodiphenylmethane, p-phenylenediamine, or m-phenylenediamine (these are also collectively referred to as specific divalent organic groups).

聚合物(B),考量提高透射率之觀點,具有2種以上上式(5)表示之重複單元,且含有具有來自上述具有脲鍵之二胺、上述具有醯胺鍵之二胺、或具有上述含氮原子之結構之二胺之2價有機基Y 5之重複單元、以及具有其他來自二胺之2價有機基Y 5之重複單元更佳。 From the viewpoint of improving transmittance, the polymer (B) preferably has two or more repeating units represented by the above formula (5), and preferably contains repeating units having a divalent organic group Y 5 derived from the above-mentioned diamine having a urea bond, the above-mentioned diamine having an amide bond, or the above-mentioned diamine having a structure containing a nitrogen atom, and preferably contains repeating units having another divalent organic group Y 5 derived from a diamine.

聚合物(B),考量來自殘留DC之殘影少之觀點,Y 5為上述特定2價有機基之重複單元之含量,也可為聚合物(B)中含有的全部重複單元之1莫耳%以上,較佳為5莫耳%以上,更佳為10莫耳%以上,又更佳為20莫耳%以上。 來自殘留DC之殘影少之觀點,聚合物(A)與聚合物(B)之含有比例(聚合物(A)/聚合物(B)之質量比)為10/90~90/10較理想,20/80~90/10更佳,20/80~80/20更理想。 <聚合物(A)及聚合物(B)之製造方法> 本發明中,作為聚合物(A)及聚合物(B)之聚醯亞胺前驅物、聚醯胺酸酯、聚醯胺酸、及該等之醯亞胺化物即聚醯亞胺,例如可按如WO2013/157586號公報記載之既知之方法合成。 In polymer (B), from the viewpoint of leaving less residual DC, Y5 is the content of the repeating unit of the specific divalent organic group, and may be 1 mol% or more of all the repeating units contained in polymer (B), preferably 5 mol% or more, more preferably 10 mol% or more, and even more preferably 20 mol% or more. From the viewpoint of leaving less residual DC, the content ratio of polymer (A) to polymer (B) (mass ratio of polymer (A)/polymer (B)) is preferably 10/90 to 90/10, more preferably 20/80 to 90/10, and even more preferably 20/80 to 80/20. <Method for producing polymer (A) and polymer (B)> In the present invention, the polyimide precursor, polyamic acid ester, polyamic acid, and imide products thereof, i.e., polyimide, which are polymers (A) and (B), can be synthesized by a known method such as that described in WO2013/157586.

具體而言,藉由使二胺成分、及四羧酸衍生物成分於溶劑中(縮聚合)反應以合成。上述四羧酸衍生物成分,例如四羧酸二酐或其衍生物(四羧醯二鹵化物、四羧酸二酯、或四羧酸二酯二鹵化物)。聚合物(A)或(B)之一部分含有醯胺酸結構時,例如可藉由使四羧酸二酐成分與二胺成分反應,以獲得具有醯胺酸結構之聚合物(聚醯胺酸)。溶劑只要生成之聚合物會溶解即可,無特殊限制。Specifically, the synthesis is performed by reacting a diamine component and a tetracarboxylic acid derivative component in a solvent (condensation polymerization). The tetracarboxylic acid derivative component is, for example, tetracarboxylic dianhydride or its derivative (tetracarboxylic acid dihalide, tetracarboxylic acid diester, or tetracarboxylic acid diester dihalide). When a part of the polymer (A) or (B) contains an acylamidic acid structure, for example, a polymer having an acylamidic acid structure (polyacylamidic acid) can be obtained by reacting a tetracarboxylic dianhydride component with a diamine component. The solvent is not particularly limited as long as the generated polymer can be dissolved.

為了獲得聚合物(A)之聚醯亞胺前驅物之二胺成分及四羧酸衍生物成分,可因應聚合物(A)擁有之上述式(1)、式(2)、式(2’)、式(3)、式(4)表示之重複單元選用以獲得此重複單元之結構。In order to obtain the diamine component and the tetracarboxylic acid derivative component of the polyimide precursor of the polymer (A), the structure of the repeating unit can be obtained by selecting the repeating unit represented by the above formula (1), formula (2), formula (2'), formula (3) and formula (4) possessed by the polymer (A).

例如:具有聚合物(A)擁有之式(1)表示之重複單元時,二胺成分,使用具有-N(Z)-Y 1-N(Z)-之結構(Y 1表示2-甲基-1,4-伸苯基。Z之定義同上述。)之二胺(以下也稱為特定二胺。),又,四羧酸衍生物成分使用具有下式(mt)之結構之四羧酸衍生物。 For example, when the polymer (A) has a repeating unit represented by the formula (1), a diamine having a structure of -N(Z)-Y 1 -N(Z)- (Y 1 represents 2-methyl-1,4-phenylene group. Z has the same definition as above) (hereinafter also referred to as specific diamine) is used as the diamine component, and a tetracarboxylic acid derivative having a structure of the following formula (mt) is used as the tetracarboxylic acid derivative component.

[化30] [Chemistry 30]

用以獲得具有聚合物(A)擁有之式(2)、式(2’)、式(3)、式(4)表示之重複單元之聚合物(A)之聚醯亞胺前驅物時使用之二胺成分及四羧酸衍生物成分,可分別依獲得具有上述式(1)表示之重複單元之聚醯亞胺前驅物時使用之二胺及四羧酸衍生物選擇並使用。The diamine component and the tetracarboxylic acid derivative component used to obtain the polyimide precursor of the polymer (A) having the repeating units represented by the formula (2), the formula (2'), the formula (3) and the formula (4) possessed by the polymer (A) can be selected and used respectively according to the diamine and the tetracarboxylic acid derivative used to obtain the polyimide precursor having the repeating units represented by the above formula (1).

又,用以獲得聚合物(B)之聚醯亞胺前驅物之二胺成分及四羧酸衍生物成分,各自選用以獲得聚合物(B)擁有之上述式(5)表示之重複單元之結構。亦即二胺成分,使用具有-N(Z)-Y 5-N(Z)-之結構(Y 5、Z之定義同上述。)之二胺,四羧酸衍生物成分使用具有X 5之結構(X 5之定義同上述。)之四羧酸衍生物。 Furthermore, the diamine component and the tetracarboxylic acid derivative component of the polyimide precursor for obtaining the polymer (B) are each selected to obtain the structure of the repeating unit represented by the above formula (5) possessed by the polymer (B). That is, the diamine component is a diamine having a structure of -N(Z)-Y 5 -N(Z)- (Y 5 and Z have the same definitions as above), and the tetracarboxylic acid derivative component is a tetracarboxylic acid derivative having a structure of X 5 (X 5 has the same definition as above).

使二胺成分與四羧酸衍生物成分反應時之上述溶劑之具體例,例如N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸、1,3-二甲基-2-咪唑啶酮。又,聚合物之溶劑溶解性高時,可使用甲乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮、或下列式[D-1]~式[D-3]表示之溶劑。Specific examples of the above-mentioned solvent when the diamine component and the tetracarboxylic acid derivative component are reacted include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, and 1,3-dimethyl-2-imidazolidinone. In addition, when the polymer has high solvent solubility, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, or solvents represented by the following formulas [D-1] to [D-3] can be used.

[化31] [Chemistry 31]

式[D-1]中,D 1表示碳數1~3之烷基,式[D-2]中,D 2表示碳數1~3之烷基,式[D-3]中,D 3表示碳數1~4之烷基。 In formula [D-1], D1 represents an alkyl group having 1 to 3 carbon atoms, in formula [D-2], D2 represents an alkyl group having 1 to 3 carbon atoms, and in formula [D-3], D3 represents an alkyl group having 1 to 4 carbon atoms.

此等溶劑可單獨使用也可混合使用。又,即使是聚合物不溶解的溶劑,也可在生成之聚合物不析出之範圍內混合在上述溶劑使用。These solvents may be used alone or in combination. Furthermore, even a solvent in which the polymer is insoluble may be mixed with the above solvents to the extent that the generated polymer does not precipitate.

使二胺成分與四羧酸衍生物成分於溶劑中反應時,反應可於任意濃度進行,但較佳為1~50質量%,更佳為5~30質量%。反應初期於高濃度進行,之後追加溶劑亦可。When the diamine component and the tetracarboxylic acid derivative component are reacted in a solvent, the reaction can be carried out at any concentration, but is preferably 1 to 50% by mass, more preferably 5 to 30% by mass. The reaction may be carried out at a high concentration in the initial stage, and then the solvent may be added.

反應中,二胺成分之合計莫耳數與四羧酸衍生物成分之合計莫耳數之比(四羧酸衍生物成分之合計莫耳數/二胺成分之合計莫耳數)為0.8~1.2較佳。和通常之縮聚合反應同樣,此莫耳比越接近1.0則生成之聚合物(A)、聚合物(B)之分子量越大。In the reaction, the ratio of the total molar number of the diamine component to the total molar number of the tetracarboxylic acid derivative component (total molar number of the tetracarboxylic acid derivative component/total molar number of the diamine component) is preferably 0.8 to 1.2. As in a conventional polycondensation reaction, the closer this molar ratio is to 1.0, the greater the molecular weight of the generated polymer (A) and polymer (B).

聚醯胺酸酯,可藉由例如:[I]使上述方法獲得之聚醯胺酸與酯化劑反應之方法、[II]使四羧酸二酯與二胺反應之方法、[III]使四羧酸二酯二鹵化物與二胺反應之方法等既知之方法獲得。The polyamic acid ester can be obtained by a known method such as [I] a method of reacting the polyamic acid obtained by the above method with an esterifying agent, [II] a method of reacting a tetracarboxylic acid diester with a diamine, or [III] a method of reacting a tetracarboxylic acid diester dihalide with a diamine.

獲得聚醯亞胺之方法,可列舉將含有上述反應獲得之聚醯胺酸、聚醯胺酸酯等聚醯亞胺前驅物之溶液直接進行加熱之熱醯亞胺化、或於上述溶液添加觸媒之觸媒醯亞胺化。The method for obtaining polyimide may include directly heating a solution containing a polyimide precursor such as polyamic acid, polyamic acid ester, etc. obtained by the above reaction for thermal imidization, or adding a catalyst to the above solution for catalytic imidization.

本發明之聚合物(A)中之聚醯亞胺,係上述聚醯亞胺前驅物具有之重複單元一部分或全部閉環。上述聚醯亞胺中,醯亞胺化率較佳為20~95%,較佳為30~95%,更佳為50~95%。 <聚合物之溶液黏度、分子量> 本發明之聚合物(A)中之聚醯胺酸、聚醯胺酸酯及聚醯亞胺,當製成濃度10~15質量%之溶液時,例如帶有10~1000mPa・s之溶液黏度時於作業性之觀點較理想,但無特殊限制。又,上述聚合物之溶液黏度(mPa・s),係使用該聚合物之良溶劑(例如:γ-丁內酯、N-甲基-2-吡咯烷酮等)製備成濃度10~15質量%之聚合物溶液,使用E型旋轉黏度計於25℃測定之值。 The polyimide in the polymer (A) of the present invention is a polyimide precursor having partially or completely closed ring repeating units. In the polyimide, the imidization rate is preferably 20-95%, preferably 30-95%, and more preferably 50-95%. <Solution viscosity and molecular weight of polymer> The polyamine acid, polyamine ester and polyimide in the polymer (A) of the present invention are preferably prepared into a solution with a concentration of 10-15 mass %, for example, with a solution viscosity of 10-1000 mPa·s from the viewpoint of workability, but there is no special restriction. In addition, the solution viscosity (mPa・s) of the above polymer is the value measured at 25°C using an E-type rotational viscometer to prepare a polymer solution with a concentration of 10~15 mass% using a good solvent for the polymer (e.g., γ-butyrolactone, N-methyl-2-pyrrolidone, etc.).

上述聚醯胺酸、聚醯胺酸酯及聚醯亞胺利用凝膠滲透層析(GPC)測定之聚苯乙烯換算之重量平均分子量(Mw)較佳為1,000~500,000,更佳為2,000~300,000。又,Mw與利用GPC測定之聚苯乙烯換算之數量平均分子量(Mn)之比表示之分子量分布(Mw/Mn),較佳為15以下,更佳為10以下。藉由在此分子量範圍,能夠確保液晶顯示元件之良好配向性及安定性。 <封端劑> 合成本發明之聚合物(A)、聚合物(B)時,可使用如上述四羧酸衍生物成分、及二胺成分,以及適當的封端劑,製成末端密封型之聚合物。末端密封型之聚合物,具有使由塗膜獲得之液晶配向膜之膜硬度提升、密封劑與液晶配向膜之密合特性提升的效果。 The weight average molecular weight (Mw) of the polyamine, polyamine ester and polyimide measured by gel permeation chromatography (GPC) in terms of polystyrene is preferably 1,000 to 500,000, more preferably 2,000 to 300,000. In addition, the molecular weight distribution (Mw/Mn) represented by the ratio of Mw to the number average molecular weight (Mn) measured by GPC in terms of polystyrene is preferably 15 or less, more preferably 10 or less. Within this molecular weight range, good orientation and stability of the liquid crystal display element can be ensured. <End Capping Agent> When synthesizing the polymer (A) and polymer (B) of the present invention, the tetracarboxylic acid derivative component and the diamine component as described above, as well as an appropriate end capping agent, can be used to prepare an end-sealed polymer. The end-sealed polymer has the effect of increasing the film hardness of the liquid crystal alignment film obtained by coating and improving the adhesion between the sealant and the liquid crystal alignment film.

本發明中之聚合物(A)、聚合物(B)之末端,例如胺基、羧基、酸酐基或該等之衍生物。胺基、羧基、酸酐基、異氰酸酯基可藉由通常之縮合反應獲得、或藉由使用以下之封端劑將末端予以密封以獲得,例如可使用以下之封端劑同樣地獲得。The terminal of polymer (A) and polymer (B) in the present invention is, for example, an amine group, a carboxyl group, an anhydride group or a derivative thereof. The amine group, the carboxyl group, the anhydride group, and the isocyanate group can be obtained by a conventional condensation reaction, or by sealing the terminal with the following end-capping agent, for example, the following end-capping agent can be used to obtain the same.

封端劑,例如:乙酸酐、馬來酸酐、奈地酸酐、鄰苯二甲酸酐、衣康酸酐、環己烷二羧酸酐、3-羥基鄰苯二甲酸酐、偏苯三甲酸酐、3-(3-三甲氧基矽基)丙基)-3,4-二氫呋喃-2,5-二酮、4,5,6,7-四氟異苯并呋喃-1,3-二酮、4-乙炔基鄰苯二甲酸酐等酸一酐;二碳酸二第三丁酯、二碳酸二烯丙酯等二碳酸二酯化合物;丙烯醯氯、甲基丙烯醯氯、菸鹼醯氯等氯羰基化合物;苯胺、2-胺基苯酚、3-胺基苯酚、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺等單胺化合物;異氰酸乙酯、異氰酸苯酯、異氰酸萘酯、2-丙烯醯氧基乙基異氰酸酯及2-甲基丙烯醯氧乙基異氰酸酯等具有不飽和鍵之異氰酸酯等單異氰酸酯化合物;異硫氰酸乙酯、異硫氰酸烯丙酯等異硫氰酸酯化合物等。End-capping agents, for example: acetic anhydride, maleic anhydride, neddic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3-(3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione, 4-ethynylphthalic anhydride and other acid anhydrides; dicarbonic acid diester compounds such as di-tert-butyl dicarbonate and diallyl dicarbonate; chlorocarbonyl compounds such as acrylyl chloride, methacrylic chloride, nicotinyl chloride; aniline, 2- -aminophenol, 3-aminophenol, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine and the like monoamine compounds; isocyanate compounds having unsaturated bonds such as ethyl isocyanate, phenyl isocyanate, naphthyl isocyanate, 2-acryloyloxyethyl isocyanate and 2-methacryloyloxyethyl isocyanate and the like monoisocyanate compounds; isothiocyanate compounds such as ethyl isothiocyanate and allyl isothiocyanate and the like.

封端劑之使用比例,相對於使用之二胺成分之合計100莫耳份為0.01~20莫耳份較理想,0.01~10莫耳份更理想。 <液晶配向劑> 本發明之液晶配向劑,含有聚合物(A)並視需要含有聚合物(B)。本發明之液晶配向劑,除了聚合物(A)、聚合物(B)也可含有其他聚合物。若舉其他聚合物之具體例,可列舉選自於由聚矽氧烷、聚酯、聚醯胺、聚脲、聚胺甲酸酯、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯衍生物、聚(苯乙烯-馬來酸酐)共聚物、聚(異丁烯-馬來酸酐)共聚物、聚(乙烯醚-馬來酸酐)共聚物、聚(苯乙烯-苯基馬來醯亞胺)衍生物、聚(甲基)丙烯酸酯構成之群組中之聚合物等。 The use ratio of the end-capping agent is preferably 0.01 to 20 moles, and more preferably 0.01 to 10 moles, relative to 100 moles of the total diamine components used. <Liquid crystal alignment agent> The liquid crystal alignment agent of the present invention contains polymer (A) and, if necessary, polymer (B). The liquid crystal alignment agent of the present invention may contain other polymers in addition to polymer (A) and polymer (B). Specific examples of other polymers include polymers selected from the group consisting of polysiloxane, polyester, polyamide, polyurea, polyurethane, polyorganosiloxane, cellulose derivatives, polyacetal, polystyrene derivatives, poly(styrene-maleic anhydride) copolymers, poly(isobutylene-maleic anhydride) copolymers, poly(vinyl ether-maleic anhydride) copolymers, poly(styrene-phenylmaleimide) derivatives, and poly(meth)acrylates.

聚(苯乙烯-馬來酸酐)共聚物之具體例可列舉SMA1000、2000、3000(Cray Valley公司製)、GSM301(GIFUSHELLAC製造所公司製)等,聚(異丁烯-馬來酸酐)共聚物之具體例可列舉ISOBAM-600(可樂麗公司製),聚(乙烯醚-馬來酸酐)共聚物之具體例可列舉Gantrez AN-139(甲基乙烯醚馬來酸酐樹脂、ASHLAND公司製)。其他聚合物可單獨使用一種也可將二種以上組合使用。其他聚合物之含有比例相對於液晶配向劑中含有的聚合物之合計100質量份宜為90質量份以下較理想,10~90質量份更佳,20~80質量份更理想。Specific examples of poly(styrene-maleic anhydride) copolymers include SMA1000, 2000, 3000 (manufactured by Cray Valley Corporation), GSM301 (manufactured by GIFUSHELLAC Manufacturing Co., Ltd.), etc. Specific examples of poly(isobutylene-maleic anhydride) copolymers include ISOBAM-600 (manufactured by Kuraray Corporation), and specific examples of poly(vinyl ether-maleic anhydride) copolymers include Gantrez AN-139 (methyl vinyl ether maleic anhydride resin, manufactured by ASHLAND Corporation). Other polymers may be used alone or in combination of two or more. The content ratio of other polymers relative to 100 parts by weight of the total polymers contained in the liquid crystal alignment agent is preferably 90 parts by weight or less, more preferably 10 to 90 parts by weight, and even more preferably 20 to 80 parts by weight.

液晶配向劑係為了製作液晶配向膜而使用,考量形成均勻薄膜之觀點,採取塗佈液之形態。本發明之液晶配向劑亦宜為含有上述聚合物成分及有機溶劑之塗佈液較佳。此時,液晶配向劑中之聚合物之濃度,可依欲形成之塗膜之厚度之設定而適當變更。考量形成均勻且無缺陷之塗膜之觀點,為1質量%以上較理想,考量溶液之保存安定性之觀點,為10質量%以下較佳。尤其理想聚合物之濃度為2~8質量%。The liquid crystal alignment agent is used to make a liquid crystal alignment film. Considering the formation of a uniform film, it is in the form of a coating liquid. The liquid crystal alignment agent of the present invention is preferably a coating liquid containing the above-mentioned polymer component and an organic solvent. At this time, the concentration of the polymer in the liquid crystal alignment agent can be appropriately changed according to the setting of the thickness of the coating to be formed. Considering the formation of a uniform and defect-free coating, it is ideal to be more than 1% by mass, and considering the storage stability of the solution, it is preferably less than 10% by mass. In particular, the ideal polymer concentration is 2~8% by mass.

液晶配向劑含有之有機溶劑,只要聚合物成分會均勻溶解即無特殊限制。其具體例可列舉N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基乳醯胺、N,N-二甲基丙醯胺、四甲基脲、N,N-二乙基甲醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、γ-戊內酯、1,3-二甲基-2-咪唑啶酮、甲乙酮、環己酮、環戊酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、N-(正丙基)-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-(正丁基)-2-吡咯烷酮、N-(第三丁基)-2-吡咯烷酮、N-(正戊基)-2-吡咯烷酮、N-甲氧基丙基-2-吡咯烷酮、N-乙氧基乙基-2-吡咯烷酮、N-甲氧基丁基-2-吡咯烷酮、N-環己基-2-吡咯烷酮(它們也總稱「良溶劑」)。其中,N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺或γ-丁內酯為較佳。良溶劑之含量為液晶配向劑中含有的溶劑全體之20~99質量%較佳,20~90質量%更佳,30~80質量%尤佳。The organic solvent contained in the liquid crystal alignment agent is not particularly limited as long as the polymer component can be uniformly dissolved. Specific examples thereof include N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N,N-dimethylpropionamide, tetramethylurea, N,N-diethylformamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy The good solvents include N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone, and N-cyclohexyl-2-pyrrolidone (these are also collectively referred to as "good solvents"). Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide or γ-butyrolactone is preferred. The content of the good solvent is preferably 20-99 mass % of the total solvent contained in the liquid crystal alignment agent, more preferably 20-90 mass % and even more preferably 30-80 mass % .

又,液晶配向劑含有之有機溶劑,宜使用除了上述溶劑尚併用為了使塗佈液晶配向劑時之塗佈性、塗膜之表面平滑性提升之溶劑(亦稱不良溶劑)之混合溶劑較佳。不良溶劑之含量為液晶配向劑中含有的溶劑全體的1~80質量%較理想,10~80質量%更佳,20~70質量%尤佳。不良溶劑之種類及含量可因應液晶配向劑之塗佈裝置、塗佈條件、塗佈環境等適當選擇。In addition, the organic solvent contained in the liquid crystal alignment agent is preferably a mixed solvent containing, in addition to the above solvents, a solvent (also called a bad solvent) for improving the coating property and surface smoothness of the coating film when the liquid crystal alignment agent is applied. The content of the bad solvent is preferably 1-80% by mass of the total solvent contained in the liquid crystal alignment agent, 10-80% by mass is more preferred, and 20-70% by mass is particularly preferred. The type and content of the bad solvent can be appropriately selected according to the coating device, coating conditions, coating environment, etc. of the liquid crystal alignment agent.

上述不良溶劑之具體例如下,但不限定於此等。Specific examples of the above-mentioned bad solvent are as follows, but are not limited thereto.

例如,二異丙醚、二異丁醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、4-羥基-4-甲基-2-戊酮、二乙二醇甲基乙醚、二乙二醇二丁醚、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸伸丙酯、碳酸伸乙酯、乙二醇單丁醚、乙二醇單異戊醚、乙二醇單己醚、丙二醇單甲醚、丙二醇單丁醚、1-(2-丁氧基乙氧基)-2-丙醇、2-(2-丁氧基乙氧基)-1-丙醇、丙二醇單甲醚乙酸酯、丙二醇二乙酸酯、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、乙二醇單丁醚乙酸酯、二乙二醇單丙醚、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、丙二醇二乙酸酯、乙酸正丁酯、乙酸丙二醇單乙醚、乙酸環己酯、乙酸4-甲基-2-戊酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸正丁酯、乳酸異戊酯、二乙二醇單乙醚、二異丁基酮(2,6-二甲基-4-庚酮)等。For example, diisopropyl ether, diisobutyl ether, diisobutyl carbinol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol methyl ethyl ether, diethylene glycol dibutyl ether, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, ethylene glycol monoacetate, ethylene glycol diacetate, propylene carbonate, ethyl carbonate, ethylene glycol monobutyl ether, ethylene glycol monoisopentyl ether, ethylene glycol monohexyl ether, propylene glycol monomethyl ether, propylene glycol monobutyl ether, 1-(2-butoxyethoxy)-2-propanol, 2-(2-butoxyethoxy)-2-propanol, )-1-propanol, propylene glycol monomethyl ether acetate, propylene glycol diacetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monopropyl ether, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, propylene glycol diacetate, n-butyl acetate, propylene glycol monoethyl ether, cyclohexyl acetate, 4-methyl-2-pentyl acetate, 3-methoxypropionic acid methyl ester, 3-ethoxypropionic acid ethyl ester, 3-methoxypropionic acid ethyl ester, 3-methoxypropionic acid propyl ester, 3-methoxypropionic acid butyl ester, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, diisobutyl ketone (2,6-dimethyl-4-heptanone), etc.

不良溶劑之中,二異丁基甲醇、丙二醇單丁醚、丙二醇二乙酸酯、二乙二醇二乙醚、二丙二醇單甲醚、二丙二醇二甲醚、4-羥基-4-甲基-2-戊酮、乙二醇單丁醚、乙二醇單丁醚乙酸酯、或二異丁基酮為較佳。Among the poor solvents, diisobutyl carbinol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, or diisobutyl ketone is preferred.

良溶劑與不良溶劑之理想溶劑之組合,例如N-甲基-2-吡咯烷酮與乙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與乙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚、N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮、N-乙基-2-吡咯烷酮與丙二醇二乙酸酯、N,N-二甲基乳醯胺與二異丁基酮、N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯、N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯、N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯與丙二醇單丁醚、N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯與二乙二醇單丙醚、N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯與二乙二醇單丙醚、N-甲基-2-吡咯烷酮與乙二醇單丁醚乙酸酯、N-乙基-2-吡咯烷酮與二丙二醇二甲醚、N,N-二甲基乳醯胺與乙二醇單丁醚、N,N-二甲基乳醯胺與丙二醇二乙酸酯、N-乙基-2-吡咯烷酮與二乙二醇二乙醚、N-乙基-2-吡咯烷酮與二乙二醇單乙醚與丁基賽珞蘇乙酸酯、N-甲基-2-吡咯烷酮與二乙二醇單甲醚與丁基賽珞蘇乙酸酯、N,N-二甲基乳醯胺與二乙二醇二乙醚、N-甲基-2-吡咯烷酮與γ-丁內酯與4-羥基-4-甲基-2-戊酮與二乙二醇二乙醚、N-乙基-2-吡咯烷酮與N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮、N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二異丁基酮、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二丙二醇單甲醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯、N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二丙二醇二甲醚、γ-丁內酯與4-羥基-4-甲基-2-戊酮與二異丁基酮、γ-丁內酯與4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丁基酮、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丙醚、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丁基甲醇、N-甲基-2-吡咯烷酮與γ-丁內酯與二丙二醇二甲醚、N-甲基-2-吡咯烷酮與丙二醇單丁醚與二丙二醇二甲醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與二乙二醇二乙醚與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚與丙二醇二乙酸酯、N-乙基-2-吡咯烷酮與丙二醇單丁醚與二異丁基酮、N-乙基-2-吡咯烷酮與γ-丁內酯與二異丁基酮、N-乙基-2-吡咯烷酮與N,N-二甲基乳醯胺與二異丁基酮、N-甲基-2-吡咯烷酮與乙二醇單丁醚與乙二醇單丁醚乙酸酯、γ-丁內酯與乙二醇單丁醚乙酸酯與二丙二醇二甲醚、N-乙基-2-吡咯烷酮與乙二醇單丁醚乙酸酯與丙二醇二甲醚、N-甲基-2-吡咯烷酮與乙酸4-甲基-2-戊酯與乙二醇單丁醚、N-乙基-2-吡咯烷酮與乙酸環己酯與二丙酮醇環己酮與丙二醇單甲醚、環戊酮與丙二醇單甲醚、N-甲基-2-吡咯烷酮與環己酮與丙二醇單甲醚等。Ideal solvent combinations of good solvents and poor solvents, such as N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone, N-ethyl-2-pyrrolidone and propylene glycol diacetate, N,N-dimethyl lactamide and diisopropyl ester. Butyl ketone, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether, N-Methyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate, N-ethyl-2-pyrrolidone and dipropylene glycol dimethyl ether, N,N-dimethyl lactamide and ethylene glycol monobutyl ether, N,N-dimethyl lactamide and propylene glycol diacetate, N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone and diethylene glycol monoethyl ether and butyl cylosulacetate, N-methyl-2-pyrrolidone and diethylene glycol monomethyl ether and butyl cylosulacetate, N,N-dimethyl lactamide With diethylene glycol diethyl ether, N-methyl-2-pyrrolidone and gamma-butyrolactone and 4-hydroxy-4-methyl-2-pentanone with diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone and N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone, N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone with propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone with diisobutyl ketone, N-methyl-2-pyrrolidone and 4-Hydroxy-4-methyl-2-pentanone and dipropylene glycol monomethyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate, N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol dimethyl ether, γ-butyrolactone and 4-hydroxy-4-methyl-2-pentanone and diisobutyl ketone, γ-butyrolactone and 4-hydroxy-4- Methyl-2-pentanone and propylene glycol diacetate, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diisobutyl ketone, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diisopropyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diisobutyl carbinol, N-methyl-2-pyrrolidone and γ-butyrolactone and dipropylene glycol dimethyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and dipropylene glycol dimethyl ether, N-ethyl-2 -Pyrrolidone and propylene glycol monobutyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether and propylene glycol diacetate, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether and diisobutyl ketone, N-ethyl-2-pyrrolidone and γ-butyrolactone and diisobutyl ketone, N-ethyl-2-pyrrolidone and N,N-dimethyllactamide and diisobutyl ketone, N-methyl-2-pyrrolidone and ethyl Glycol monobutyl ether and ethylene glycol monobutyl ether acetate, γ-butyrolactone and ethylene glycol monobutyl ether acetate and dipropylene glycol dimethyl ether, N-ethyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate and propylene glycol dimethyl ether, N-methyl-2-pyrrolidone and 4-methyl-2-pentyl acetate and ethylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and cyclohexyl acetate and diacetone alcohol cyclohexanone and propylene glycol monomethyl ether, cyclopentanone and propylene glycol monomethyl ether, N-methyl-2-pyrrolidone and cyclohexanone and propylene glycol monomethyl ether, etc.

本發明之液晶配向劑亦可追加地含有聚合物成分及有機溶劑以外之成分(以下亦稱添加劑成分)。如此的添加劑成分可列舉:用以使液晶配向膜與基板之密合性、液晶配向膜與密封劑之密合性提高之密合助劑、用以使液晶配向膜之強度提高之化合物(以下亦稱交聯性化合物)、用以促進醯亞胺化之化合物、用以調整液晶配向膜之介電常數、電阻之介電體、導電物質等。The liquid crystal alignment agent of the present invention may also contain additional components other than the polymer component and the organic solvent (hereinafter also referred to as additive components). Such additive components include: adhesion aids for improving the adhesion between the liquid crystal alignment film and the substrate, and the adhesion between the liquid crystal alignment film and the sealant, compounds for improving the strength of the liquid crystal alignment film (hereinafter also referred to as cross-linking compounds), compounds for promoting imidization, dielectrics for adjusting the dielectric constant and resistance of the liquid crystal alignment film, conductive substances, etc.

針對上述交聯性化合物,考量理想地獲得本發明之效果之觀點,可列舉具有選自於由環氧乙烷基、環氧丙烷基、受保護異氰酸酯基、受保護異硫氰酸酯基、含有㗁唑啉環結構之基、含有米氏酸(Meldrum's acid)結構之基、環碳酸酯基、及下式(d)表示之基構成之群組中之至少1種基之化合物、或下式(e)表示之化合物。With respect to the above-mentioned crosslinking compound, from the viewpoint of ideally obtaining the effect of the present invention, there can be cited compounds having at least one group selected from the group consisting of an oxirane group, a propylene oxide group, a protected isocyanate group, a protected isothiocyanate group, a group containing an oxazoline ring structure, a group containing a Meldrum's acid structure, a cyclic carbonate group, and a group represented by the following formula (d), or a compound represented by the following formula (e).

[化32] [Chemistry 32]

上式(d)中,R 2及R 3各自獨立地為氫原子、碳數1~3之烷基、或「*-CH 2-OH」。上式(e)中,A表示具有芳香環之(m+n)價有機基,R、R’各自獨立地表示氫原子或碳數1~5之烷基,m為1~6,n為0~4。上述芳香環之任意氫原子也可被鹵素原子、碳數1~10之烷基、碳數2~10之烯基、碳數1~10之烷氧基、碳數1~10之氟烷基、碳數2~10之氟烯基、或碳數1~10之氟烷氧基取代。 In the above formula (d), R 2 and R 3 are each independently a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, or "*-CH 2 -OH". In the above formula (e), A represents an (m+n)-valent organic group having an aromatic ring, R and R' are each independently a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, m is 1 to 6, and n is 0 to 4. Any hydrogen atom in the above aromatic ring may be substituted by a halogen atom, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluoroalkyl group having 1 to 10 carbon atoms, a fluoroalkenyl group having 2 to 10 carbon atoms, or a fluoroalkoxy group having 1 to 10 carbon atoms.

具有環氧乙烷基之化合物之具體例,可列舉日本特開平10-338880號公報之[0037]記載之化合物、WO2017/170483號公報記載之骨架中帶有三𠯤環之化合物等具有2個以上之環氧乙烷基之化合物。該等之中,亦可為N,N,N’,N’-四環氧丙基間二甲苯二胺、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、N,N,N’,N’-四環氧丙基-4、4’-二胺基二苯基甲烷、N,N,N’,N’-四環氧丙基-對苯二胺、下式(r-1)~(r-3)表示之化合物等含有氮原子之化合物。Specific examples of compounds having an oxirane group include compounds described in [0037] of Japanese Patent Application Laid-Open No. 10-338880 and compounds having a tricyclic ring in the skeleton described in WO2017/170483. Among them, compounds containing nitrogen atoms such as N,N,N',N'-tetraoxopropyl-m-xylene diamine, 1,3-bis(N,N-dioxopropylaminomethyl)cyclohexane, N,N,N',N'-tetraoxopropyl-4,4'-diaminodiphenylmethane, N,N,N',N'-tetraoxopropyl-p-phenylenediamine, and compounds represented by the following formulas (r-1) to (r-3) may be mentioned.

[化33] [Chemistry 33]

具有環氧丙烷基之化合物之具體例可列舉WO2011/132751號公報之[0170]~[0175]記載之具有2個以上之環氧丙烷基之化合物等。Specific examples of the compound having an propylene oxide group include compounds having two or more propylene oxide groups described in [0170] to [0175] of WO2011/132751.

具有受保護異氰酸酯基之化合物之具體例,可列舉日本特開2014-224978號公報之[0046]~[0047]記載之具有2個以上之受保護異氰酸酯基之化合物、WO2015/141598號公報之[0119]~[0120]記載之具有3個以上之受保護異氰酸酯基之化合物等,也可為下式(bi-1)~(bi-3)表示之化合物。Specific examples of the compound having a protected isocyanate group include compounds having two or more protected isocyanate groups described in [0046] to [0047] of JP-A-2014-224978, compounds having three or more protected isocyanate groups described in [0119] to [0120] of WO2015/141598, and compounds represented by the following formulas (bi-1) to (bi-3).

[化34] [Chemistry 34]

具有受保護異硫氰酸酯基之化合物之具體例,可列舉日本特開2016-200798號公報記載之具有2個以上之受保護異硫氰酸酯基之化合物。Specific examples of the compound having a protected isothiocyanate group include compounds having two or more protected isothiocyanate groups described in Japanese Patent Application Laid-Open No. 2016-200798.

具有含有㗁唑啉環結構之基之化合物之具體例,可列舉日本特開2007-286597號公報之[0115]記載之含有2個以上之㗁唑啉環結構之化合物。Specific examples of the compound having a group containing an oxazoline ring structure include compounds containing two or more oxazoline ring structures described in [0115] of JP-A-2007-286597.

具有含有米氏酸結構之基之化合物之具體例,可列舉WO2012/091088號公報記載之有2個以上之米氏酸結構之化合物。Specific examples of the compound having a group containing a Michaelis acid structure include compounds having two or more Michaelis acid structures described in WO2012/091088.

具有環碳酸酯基之化合物之具體例可列舉WO2011/155577號公報記載之化合物。Specific examples of the compound having a cyclocarbonate group include the compounds described in WO2011/155577.

上式(d)表示之基之R 2、R 3之碳數1~3之烷基可列舉甲基、乙基、丙基、異丙基。 The alkyl group having 1 to 3 carbon atoms in R 2 and R 3 of the group represented by the above formula (d) may be methyl, ethyl, propyl or isopropyl.

具有上式(d)表示之基之化合物之具體例可列舉WO2015/072554號公報、日本特開2016-118753號公報之[0058]記載之具有2個以上之上式(d)表示之基之化合物、日本特開2016-200798號公報記載之化合物等,也可為下式(hd-1)~(hd-8)表示之化合物。Specific examples of the compound having a group represented by the above formula (d) include compounds having two or more groups represented by the above formula (d) described in [0058] of WO2015/072554, Japanese Patent Application Publication No. 2016-118753, compounds described in Japanese Patent Application Publication No. 2016-200798, and compounds represented by the following formulas (hd-1) to (hd-8) may also be mentioned.

[化35] [Chemistry 35]

上式(e)之A中之具有芳香環之(m+n)價有機基,可列舉碳數6~30之(m+n)價之芳香族烴基、碳數6~30之芳香族烴基直接或介隔連結基而鍵結成之(m+n)價有機基、具有芳香族雜環之(m+n)價之基。上述芳香族烴基,例如苯、萘等。針對芳香族雜環,可列舉於上述含有氮原子之雜環例示之結構中以吡啶環為代表之芳香族雜環。上述連結基可列舉碳數1~10之伸烷基、-NR-(R為氫原子或碳數1~5之烷基)、或從上述伸烷基排除1個氫原子之基、2價或3價之環己烷環等。又,上述伸烷基之任意氫原子也可被碳數1~6之烷基、氟原子或三氟甲基等有機基取代。上式(e)之R、R’中之碳數1~5之烷基,可列舉上式(g)中之R 1~R 4例示之烷基之具體例。 The (m+n)-valent organic group having an aromatic ring in A of the above formula (e) may include an (m+n)-valent aromatic alkyl group having 6 to 30 carbon atoms, an (m+n)-valent organic group formed by directly or via a linking group an aromatic alkyl group having 6 to 30 carbon atoms, and an (m+n)-valent group having an aromatic heterocyclic ring. The above aromatic alkyl group may be benzene, naphthalene, etc. As for the aromatic heterocyclic ring, an aromatic heterocyclic ring represented by a pyridine ring in the structure exemplified for the above heterocyclic ring containing a nitrogen atom may be listed. The above linking group may include an alkylene group having 1 to 10 carbon atoms, -NR- (R is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms), or a group excluding one hydrogen atom from the above alkylene group, a divalent or trivalent cyclohexane ring, etc. In addition, any hydrogen atom of the above alkylene group may be substituted by an alkyl group having 1 to 6 carbon atoms, a fluorine atom or an organic group such as a trifluoromethyl group. Specific examples of the alkyl group having 1 to 5 carbon atoms in R and R' in the above formula (e) include the alkyl groups exemplified in R1 to R4 in the above formula (g).

上式(e)之具體例可列舉WO2010/074269號公報記載之化合物、下式(e-1)~(e-10)中之任一者表示之化合物。Specific examples of the above formula (e) include compounds described in WO2010/074269 and compounds represented by any one of the following formulas (e-1) to (e-10).

[化36] [Chemistry 36]

上述例示之化合物為交聯性化合物之一例,不限於此等。例如:WO2015/060357號公報之53頁[0105]~55頁[0116]揭示者等。又,也可將2種以上交聯性化合物組合。The compounds exemplified above are examples of crosslinking compounds, but are not limited thereto. For example, the compounds disclosed in WO2015/060357, pages 53 [0105] to 55 [0116], etc. In addition, two or more crosslinking compounds may be combined.

本發明之液晶配向劑中,交聯性化合物之含量相對於液晶配向劑中含有的聚合物成分100質量份為0.5~20質量份較佳,考量理想地獲得本發明之效果之觀點,更佳為1~15質量份。In the liquid crystal alignment agent of the present invention, the content of the crosslinking compound is preferably 0.5 to 20 parts by weight relative to 100 parts by weight of the polymer component contained in the liquid crystal alignment agent. From the perspective of ideally obtaining the effect of the present invention, it is more preferably 1 to 15 parts by weight.

上述密合助劑,例如3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、對苯乙烯基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參[3-(三甲氧基矽基)丙基]異氰尿酸酯、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-異氰酸酯丙基三乙氧基矽烷等矽烷偶聯劑。The above-mentioned adhesion aids, such as 3-aminopropyl trimethoxysilane, 3-aminopropyl triethoxysilane, 3-aminopropyl diethoxymethyl silane, 2-aminopropyl trimethoxysilane, 2-aminopropyl triethoxysilane, N-(2-aminoethyl)-3-aminopropyl trimethoxysilane, N-(2-aminoethyl)-3-aminopropyl methyl dimethoxysilane, 3-ureidopropyl trimethoxysilane, 3-ureidopropyl triethoxysilane, N-phenyl-3-aminopropyl trimethoxysilane, N-phenyl-3-aminopropyl triethoxysilane, vinyl trimethoxysilane, vinyl triethoxysilane, 2-(3,4-epoxycyclohexyl)ethyl trimethoxysilane, 3-epoxypropyloxysilane, 3-Glycyrrhizic Acid, 3-Methacryloyloxypropyl Methyl Dimethoxysilane, 3-Methacryloyloxypropyl Trimethoxysilane ... Silane coupling agents include acyloxypropylmethyldiethoxysilane, 3-methacryloyloxypropyltriethoxysilane, 3-acryloyloxypropyltrimethoxysilane, tris[3-(trimethoxysilyl)propyl]isocyanurate, 3-butylpropylmethyldimethoxysilane, 3-butylpropyltrimethoxysilane, and 3-isocyanatepropyltriethoxysilane.

使用矽烷偶聯劑時,考量理想地獲得本發明之效果之觀點,相對於液晶配向劑中含有的聚合物成分100質量份為0.1~30質量份較佳,0.1~20質量份更佳。When using a silane coupling agent, in order to ideally obtain the effect of the present invention, the amount of the silane coupling agent is preferably 0.1 to 30 parts by mass, and more preferably 0.1 to 20 parts by mass, relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.

為了促進上述醯亞胺化之化合物,宜為具有鹼性部位(例:一級胺基、脂肪族雜環(例:吡咯啶骨架)、芳香族雜環(例:咪唑環、吲哚環)、或胍基等)之化合物(惟不包括上述交聯性化合物及密合助劑。)、或煅燒時會產生上述鹼性部位之化合物較佳。更佳為煅燒時會產生上述鹼性部位之化合物,且若舉具體例,可列舉下式(B-1)~(B-17)表示之化合物。為了促進醯亞胺化之化合物之含量,相對於聚合物(A)擁有之醯胺酸、或醯胺酸酯部位1莫耳,較佳為2莫耳以下,更佳為1莫耳以下,又更佳為0.5莫耳以下。The compound for promoting the above-mentioned imidization is preferably a compound having a basic site (e.g., a primary amine group, an aliphatic heterocycle (e.g., a pyrrolidine skeleton), an aromatic heterocycle (e.g., an imidazole ring, an indole ring), or a guanidine group, etc.) (but excluding the above-mentioned cross-linking compound and a close-fitting aid.), or a compound that generates the above-mentioned basic site when calcined. More preferably, it is a compound that generates the above-mentioned basic site when calcined, and if specific examples are given, the compounds represented by the following formulas (B-1) to (B-17) can be listed. The content of the compound for promoting the imidization is preferably 2 mol or less, more preferably 1 mol or less, and even more preferably 0.5 mol or less, relative to 1 mol of the amide or amide ester site possessed by the polymer (A).

[化37] [Chemistry 37]

D表示因加熱而脫離之有機基,較佳為Boc、或Fmoc中之任一者。D有多個時,多個D彼此可相同也可不同。 本發明之液晶配向劑中,固體成分濃度(液晶配向劑之溶劑以外之成分之合計質量佔液晶配向劑之全部質量之比例)可考慮黏性、揮發性等而適當選擇,較佳為1~10質量%之範圍。 D represents an organic group that is released by heating, preferably Boc or Fmoc. When there are multiple Ds, the multiple Ds may be the same or different. In the liquid crystal alignment agent of the present invention, the solid component concentration (the ratio of the total mass of the components other than the solvent of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent) can be appropriately selected in consideration of viscosity, volatility, etc., and is preferably in the range of 1 to 10 mass%.

尤其理想的固體成分濃度之範圍,取決於在基板塗佈液晶配向劑時使用之方法而有不同。如後述步驟(1)記載,可列舉在基板塗佈液晶配向劑之方法,例如:輥塗法、旋塗法、印刷法、噴墨法等。使用輥塗法時,固體成分濃度為4~10質量%之範圍尤佳。使用旋塗法時,固體成分濃度為1.5~4.5質量%之範圍尤佳。利用印刷法時,固體成分濃度為3~9質量%之範圍,藉此使溶液黏度成為12~50mPa・s之範圍尤佳。利用噴墨法時,固體成分濃度為1~5質量%之範圍,藉此使溶液黏度成為3~15mPa・s之範圍尤佳。製備聚合物組成物時之溫度較佳為10~50℃,更佳為20~30℃。 <液晶配向膜> 本發明之液晶配向膜係從上述液晶配向劑獲得。本發明之液晶配向膜可使用在水平配向型或垂直配向型(VA型)之液晶配向膜,其中係適合IPS驅動方式或FFS驅動方式等水平配向型之液晶顯示元件之液晶配向膜。又,更宜使用在光配向處理法用之液晶配向膜。此外,可在各種技術用途有效地使用,例如亦可使用在上述用途以外之液晶配向膜(相位差薄膜用之液晶配向膜、掃描天線、液晶陣列天線用之液晶配向膜或透過散射型之液晶調光元件用之液晶配向膜)、或其他用途例如:保護膜(例:彩色濾光片用之保護膜)、間隔件膜、層間絕緣膜、抗反射膜、配線被覆膜、抗靜電薄膜、電動機絕緣膜(可撓性顯示器之閘絕緣膜)等。 The range of the ideal solid component concentration varies depending on the method used when applying the liquid crystal alignment agent to the substrate. As described in step (1) below, the methods of applying the liquid crystal alignment agent to the substrate can be listed, for example: roller coating, spin coating, printing, inkjet, etc. When roller coating is used, the solid component concentration is preferably in the range of 4 to 10 mass %. When spin coating is used, the solid component concentration is preferably in the range of 1.5 to 4.5 mass %. When printing is used, the solid component concentration is preferably in the range of 3 to 9 mass %, so that the solution viscosity is preferably in the range of 12 to 50 mPa·s. When the inkjet method is used, the solid component concentration is in the range of 1 to 5 mass %, so that the solution viscosity is preferably in the range of 3 to 15 mPa·s. The temperature when preparing the polymer composition is preferably 10 to 50°C, and more preferably 20 to 30°C. <Liquid crystal alignment film> The liquid crystal alignment film of the present invention is obtained from the above-mentioned liquid crystal alignment agent. The liquid crystal alignment film of the present invention can be used in a horizontal alignment type or a vertical alignment type (VA type) liquid crystal alignment film, among which it is a liquid crystal alignment film suitable for a horizontal alignment type liquid crystal display element such as an IPS drive method or a FFS drive method. In addition, it is more suitable to use a liquid crystal alignment film for a photo-alignment treatment method. In addition, it can be effectively used in various technical applications, such as liquid crystal alignment films other than the above applications (liquid crystal alignment films for phase difference films, scanning antennas, liquid crystal array antennas, or liquid crystal alignment films for liquid crystal dimming elements of the through-scattering type), or other applications such as protective films (e.g. protective films for color filters), spacer films, interlayer insulation films, anti-reflection films, wiring coating films, anti-static films, motor insulation films (gate insulation films for flexible displays), etc.

本發明之液晶配向膜可依例如包括以下之步驟(1)~(3),較佳為包括步驟(1)~(4)之方法予以製造。 <步驟(1):將液晶配向劑塗佈在基板上之步驟> 於設有經圖案化之透明導電膜之基板之一面,利用例如輥塗法、旋塗法、印刷法、噴墨法等適當的塗佈方法塗佈本發明之液晶配向劑。在此,基板只要是透明性高之基板即不特別限定,可將玻璃基板、氮化矽基板和壓克力基板、聚碳酸酯基板等塑膠基板等一起使用。又,反射型之液晶顯示元件若為僅單側的基板,則也可使用矽晶圓等不透明物,此情形時,電極也可使用鋁等會反射光之材料。又,製造IPS驅動方式或FFS驅動方式之液晶顯示元件時,使用設有由圖案化為梳齒型之透明導電膜或金屬膜構成的電極的基板、及未設電極之對向基板。 The liquid crystal alignment film of the present invention can be manufactured by, for example, the following steps (1) to (3), preferably a method including steps (1) to (4). <Step (1): Step of applying the liquid crystal alignment agent on the substrate> The liquid crystal alignment agent of the present invention is applied to one side of the substrate having a patterned transparent conductive film by a suitable coating method such as roller coating, spin coating, printing, inkjet, etc. Here, the substrate is not particularly limited as long as it is a highly transparent substrate, and a glass substrate, a silicon nitride substrate, an acrylic substrate, a polycarbonate substrate, or other plastic substrates can be used together. In addition, if the reflective liquid crystal display element is a substrate with only one side, an opaque material such as a silicon wafer can also be used. In this case, the electrode can also use a material that reflects light such as aluminum. In addition, when manufacturing an IPS drive method or FFS drive method liquid crystal display element, a substrate with an electrode composed of a comb-shaped transparent conductive film or metal film and an opposing substrate without an electrode are used.

將液晶配向劑塗佈在基板並成膜之方法,可列舉網版印刷、平版印刷、柔版印刷、噴墨法、或噴塗法等。其中,宜使用利用噴墨法進行塗佈並成膜之方法。 <步驟(2):將已塗佈之液晶配向劑進行煅燒之步驟> 步驟(2),係將已塗佈於基板上之液晶配向劑煅燒並形成膜之步驟。將液晶配向劑塗佈在基板上後,可利用熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段使溶劑蒸發,或進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化。本發明之液晶配向劑塗佈後之乾燥、煅燒步驟,可選擇任意之溫度及時間,也可進行多次。煅燒溫度,例如可於40~180℃進行。考量縮短處理之觀點,可於40~150℃進行。煅燒時間不特別限定,可列舉1~10分,較佳為1~5分。進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化時,可於上述煅燒步驟之後,例如在150~300℃,較佳為150~250℃之溫度範圍實施進行煅燒之步驟。煅燒時間不特別限定,可列舉5~40分,較佳為5~30分之煅燒時間。 Methods for coating the liquid crystal alignment agent on the substrate and forming a film include screen printing, lithography, flexographic printing, inkjet, or spray coating. Among them, the method of coating and forming a film by inkjet is preferably used. <Step (2): Step of calcining the coated liquid crystal alignment agent> Step (2) is a step of calcining the liquid crystal alignment agent coated on the substrate and forming a film. After the liquid crystal alignment agent is coated on the substrate, the solvent can be evaporated by heating means such as a hot plate, a heat circulation oven, or an IR (infrared) oven, or thermal imidization of polyamide acid or polyamide ester can be performed. The drying and calcining steps after the liquid crystal alignment agent of the present invention is applied can be carried out at any temperature and time, and can also be carried out multiple times. The calcining temperature can be, for example, 40 to 180°C. Considering the viewpoint of shortening the treatment, it can be carried out at 40 to 150°C. The calcining time is not particularly limited, and can be 1 to 10 minutes, preferably 1 to 5 minutes. When thermal imidization of polyamine or polyamine ester is carried out, the calcining step can be carried out after the above calcining step, for example, at a temperature range of 150 to 300°C, preferably 150 to 250°C. The calcining time is not particularly limited, and can be 5 to 40 minutes, preferably 5 to 30 minutes.

煅燒後之膜狀物若過薄,則液晶顯示元件之可靠性會有降低的情形,故5~300nm較理想,10~200nm更理想。 <步驟(3):對於步驟(2)獲得之膜進行配向處理之步驟> 步驟(3),係視需要對於步驟(2)獲得之膜進行配向處理之步驟。亦即,於IPS驅動方式或FFS驅動方式等水平配向型之液晶顯示元件,對於該塗膜進行配向能力賦予處理。另一方面,VA方式或PSA模式等垂直配向型之液晶顯示元件,可將形成之塗膜直接作為液晶配向膜使用,但亦可對於該塗膜實施配向能力賦予處理。液晶配向膜之配向處理方法可列舉摩擦處理法、光配向處理法,光配向處理法較理想。光配向處理法可列舉對於上述膜狀物之表面照射沿一定方向偏向之放射線,並視情形,較佳為於150~250℃之溫度進行加熱處理,並賦予液晶配向性(亦稱液晶配向能力)之方法。放射線可使用具有100~800nm之波長之紫外線或可見光線。其中,較佳為波長100~400nm,更佳為波長200~400nm之紫外線。 If the film after calcination is too thin, the reliability of the liquid crystal display element will be reduced, so 5~300nm is more ideal, and 10~200nm is more ideal. <Step (3): Step of performing an alignment treatment on the film obtained in step (2)> Step (3) is a step of performing an alignment treatment on the film obtained in step (2) as needed. That is, in a horizontal alignment type liquid crystal display element such as an IPS drive mode or a FFS drive mode, the coating is treated to impart alignment capability. On the other hand, in a vertical alignment type liquid crystal display element such as a VA mode or a PSA mode, the formed coating can be used directly as a liquid crystal alignment film, but the coating can also be treated to impart alignment capability. The alignment treatment methods of the liquid crystal alignment film can be listed as friction treatment method and optical alignment treatment method, and the optical alignment treatment method is more ideal. The optical alignment treatment method can be listed as a method of irradiating the surface of the above-mentioned film-like object with radiation biased in a certain direction, and depending on the situation, it is preferably heated at a temperature of 150~250℃, and giving liquid crystal alignment (also known as liquid crystal alignment ability). The radiation can use ultraviolet light or visible light with a wavelength of 100~800nm. Among them, ultraviolet light with a wavelength of 100~400nm is preferred, and ultraviolet light with a wavelength of 200~400nm is more preferred.

上述放射線之照射量為1~10,000mJ/cm 2較理想,100~5,000mJ/cm 2更佳,100~1,500mJ/cm 2又更佳,100~1,000mJ/cm 2尤佳,100~400mJ/cm 2更理想。以往使用液晶配向劑時,配向處理之光照射量為100~5,000mJ/cm 2,但本發明之液晶配向劑即使減低配向處理之光照射量,仍能獲得液晶配向膜面內之液晶配向性之變異(不均勻性)受抑制之液晶配向膜。 The radiation dose is preferably 1-10,000 mJ/cm 2 , more preferably 100-5,000 mJ/cm 2 , more preferably 100-1,500 mJ/cm 2 , particularly preferably 100-1,000 mJ/cm 2 , and even more preferably 100-400 mJ/cm 2. In the past, when using a liquid crystal alignment agent, the light irradiation dose for the alignment treatment was 100-5,000 mJ/cm 2. However, even if the liquid crystal alignment agent of the present invention reduces the light irradiation dose for the alignment treatment, a liquid crystal alignment film with suppressed variation (non-uniformity) of the liquid crystal alignment property within the surface of the liquid crystal alignment film can still be obtained.

又,照射放射線時,為了改善液晶配向性,也可邊將上述具有膜狀物之基板於50~250℃加熱邊進行照射。如此製作之上述液晶配向膜,能夠使液晶分子沿一定的方向安定地配向。Furthermore, when irradiating the radiation, in order to improve the liquid crystal alignment, the substrate with the film may be heated at 50-250° C. The liquid crystal alignment film prepared in this way can align the liquid crystal molecules stably in a certain direction.

又,也可對於按上述方法照射了經偏光之放射線的液晶配向膜,使用水、溶劑進行接觸處理、或將已照射放射線之液晶配向膜進行加熱處理。Furthermore, the liquid crystal alignment film irradiated with polarized radiation in the above method may be subjected to a contact treatment using water or a solvent, or the liquid crystal alignment film irradiated with radiation may be subjected to a heat treatment.

上述接觸處理使用之溶劑,只要是會將因放射線之照射而從膜狀物生成之分解物予以溶解之溶劑即無特殊限制。具體例可列舉水、甲醇、乙醇、2-丙醇、丙酮、甲乙酮、1-甲氧基-2-丙醇、1-甲氧基-2-丙醇乙酸酯、丁基賽珞蘇、乳酸乙酯、乳酸甲酯、二丙酮醇、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙酸丙酯、乙酸丁酯、乙酸環己酯等。其中,考量泛用性、溶劑之安全性之觀點,水、2-丙醇、1-甲氧基-2-丙醇或乳酸乙酯為較佳。更理想為水、1-甲氧基-2-丙醇或乳酸乙酯。溶劑可為1種也可將2種以上組合。 <步驟(4):對於在步驟(3)經配向處理之膜實施50~300℃之加熱處理之步驟> 亦可對於上述經放射線照射之塗膜進行加熱處理。該加熱處理之溫度為50~300℃較理想,120~250℃更理想。加熱處理之時間各為1~30分較佳。 <液晶顯示元件> 本發明之液晶顯示元件具備本發明之液晶配向膜,可依下列方式製造。準備2片如上述獲得之已形成液晶配向膜之基板,在對向配置之2片基板間配置液晶。具體而言,可列舉以下之2種方法。 The solvent used in the above-mentioned contact treatment is not particularly limited as long as it can dissolve the decomposition products generated from the film due to radiation exposure. Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl celecoxib, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, cyclohexyl acetate, etc. Among them, considering the versatility and safety of the solvent, water, 2-propanol, 1-methoxy-2-propanol or ethyl lactate is preferred. More preferably, water, 1-methoxy-2-propanol or ethyl lactate is preferred. The solvent may be one or a combination of two or more. <Step (4): Performing a heat treatment at 50-300°C on the film that has been oriented in step (3)> The above-mentioned coating film irradiated with radiation may also be subjected to a heat treatment. The temperature of the heat treatment is preferably 50-300°C, and 120-250°C is more ideal. The time of the heat treatment is preferably 1-30 minutes. <Liquid crystal display element> The liquid crystal display element of the present invention has the liquid crystal alignment film of the present invention and can be manufactured in the following manner. Prepare two substrates on which the liquid crystal alignment film has been formed as obtained above, and arrange liquid crystal between the two oppositely arranged substrates. Specifically, the following two methods can be listed.

第一方法,係首先,以各自的液晶配向膜面對的方式,隔著間隙(晶胞隙)將2片基板予以對向配置。然後,將2片基板的周邊部彼此使用密封劑予以貼合,對於由基板表面及密封劑區隔出的晶胞隙內通過注入孔填充液晶組成物而和膜面接觸後,將注入孔予以密封。The first method is to firstly arrange two substrates facing each other with their respective liquid crystal alignment films facing each other with a gap (cell gap) between them. Then, the peripheries of the two substrates are bonded to each other using a sealant, and the cell gap separated by the substrate surface and the sealant is filled with a liquid crystal composition through an injection hole so that it contacts the film surface, and then the injection hole is sealed.

又,第二方法,係稱為ODF(One Drop Fill)方式之方法。在已形成液晶配向膜之2片基板中之其中之一之基板上之預定處,塗佈例如紫外光硬化性密封劑,再於液晶配向膜面上之預定之數處滴加液晶組成物。之後,以液晶配向膜面對的方式,貼合另一基板而將液晶組成物推開在基板之全面而使其和膜面接觸。然後,對於基板之全面照射紫外光而使密封劑硬化。The second method is called ODF (One Drop Fill) method. For example, a UV curable sealant is applied to a predetermined location on one of the two substrates on which the liquid crystal alignment film has been formed, and then a liquid crystal composition is dripped at a predetermined number of locations on the surface of the liquid crystal alignment film. After that, the other substrate is attached in a manner that the liquid crystal alignment films face each other and the liquid crystal composition is pushed over the entire surface of the substrate to make it contact with the film surface. Then, ultraviolet light is irradiated to the entire surface of the substrate to cure the sealant.

在利用任一方法時,皆更加熱直到使用之液晶組成物成為採等向相之溫度後,緩慢冷卻到室溫,以去除液晶填充時之流動配向較理想。When using either method, the liquid crystal composition is heated until it reaches an isotropic phase and then slowly cooled to room temperature to remove the ideal flow alignment during liquid crystal filling.

又,對於塗膜進行摩擦處理時,係將2片基板以各塗膜之摩擦方向彼此成預定角度,例如:成直交或逆平行的方式予以對向配置。Furthermore, when the coating is subjected to rubbing treatment, two substrates are arranged opposite to each other in such a manner that the rubbing directions of the coatings form a predetermined angle with each other, for example, perpendicular or anti-parallel.

密封劑,例如可使用含有硬化劑及作為間隔件之氧化鋁球之環氧樹脂等。液晶可列舉向列液晶及層列液晶,其中向列液晶為較佳。The sealant may be, for example, epoxy resin containing a hardener and aluminum oxide balls as spacers. Examples of the liquid crystal include nematic liquid crystal and lamellar liquid crystal, of which nematic liquid crystal is preferred.

上述液晶組成物無特殊限制,可使用係含有至少一種液晶化合物(液晶分子)且介電常數異向性為正或負之各種液晶組成物。又,以下將介電常數異向性為正之液晶組成物也稱為正型液晶,介電異向性為負之液晶組成物也稱為負型液晶。The above-mentioned liquid crystal composition is not particularly limited, and various liquid crystal compositions containing at least one liquid crystal compound (liquid crystal molecule) and having a positive or negative dielectric anisotropy can be used. In addition, a liquid crystal composition having a positive dielectric anisotropy is also referred to as a positive liquid crystal, and a liquid crystal composition having a negative dielectric anisotropy is also referred to as a negative liquid crystal.

液晶組成物可列舉呈向列相之液晶組成物、呈層列相之液晶組成物及呈膽固醇相之液晶組成物,其中,呈向列相之液晶組成物較佳。Examples of the liquid crystal composition include a liquid crystal composition presenting a nematic phase, a liquid crystal composition presenting a lamellar phase, and a liquid crystal composition presenting a cholesteric phase, among which the liquid crystal composition presenting a nematic phase is preferred.

上述液晶組成物亦可含有具有氟原子、羥基、胺基、含氟原子之基(例如:三氟甲基)、氰基、烷基、烷氧基、烯基、異硫氰酸酯基、雜環、環烷、環烯、類固醇骨架、苯環、或萘環之液晶化合物,也可含有分子內有2個以上之展現液晶性之剛直部位(液晶原(mesogen)骨架)之化合物(例如:剛直的二個聯苯結構、或聯三苯結構以烷基連結成之雙液晶原化合物)。The above-mentioned liquid crystal composition may also contain liquid crystal compounds having fluorine atoms, hydroxyl groups, amino groups, groups containing fluorine atoms (for example, trifluoromethyl groups), cyano groups, alkyl groups, alkoxy groups, alkenyl groups, isothiocyanate groups, heterocyclic groups, cycloalkanes, cycloalkenes, steroid skeletons, benzene rings, or naphthyl rings. It may also contain compounds having two or more rigid parts (mesogen skeletons) that exhibit liquid crystallinity in the molecule (for example, a bimesogen compound in which two rigid biphenyl structures or terphenyl structures are linked by an alkyl group).

上述液晶組成物中,考量使液晶配向性提升之觀點,也可更添加添加物。如此的添加物可列舉具有聚合性基之化合物等光聚合性單體;光學活性的化合物(例:默克(股)公司製之S-811等);抗氧化劑;紫外線吸收劑;色素;消泡劑;聚合起始劑;或聚合抑制劑等。In the above-mentioned liquid crystal composition, additives may be further added from the viewpoint of improving the orientation of the liquid crystal. Such additives may include photopolymerizable monomers such as compounds having polymerizable groups; optically active compounds (e.g., S-811 manufactured by Merck & Co., Ltd.); antioxidants; ultraviolet light absorbers; pigments; defoaming agents; polymerization initiators; or polymerization inhibitors, etc.

正型液晶可列舉默克公司製之ZLI-2293、ZLI-4792、MLC-2003、MLC-2041、MLC-3019、或MLC-7081等。Examples of positive liquid crystals include ZLI-2293, ZLI-4792, MLC-2003, MLC-2041, MLC-3019, or MLC-7081 manufactured by Merck.

負型液晶,例如默克公司製之MLC-6608、MLC-6609、MLC-6610、或MLC-7026-100等。Negative liquid crystal, such as MLC-6608, MLC-6609, MLC-6610, or MLC-7026-100 manufactured by Merck.

又,含有具有聚合性基之化合物之液晶可列舉默克公司製之MLC-3023。Examples of the liquid crystal containing a compound having a polymerizable group include MLC-3023 manufactured by Merck.

並且,視需要可藉由於液晶胞之外側表面貼合偏光板以獲得液晶顯示元件。貼合在液晶胞外表面的偏光板,可列舉:以乙酸纖維素保護膜夾持邊將聚乙烯醇延伸配向邊使其吸收碘而得之稱為「H膜」之偏光薄膜而成的偏光板或H膜本身構成的偏光板。Furthermore, a liquid crystal display element can be obtained by attaching a polarizing plate to the outer surface of the liquid crystal cell as needed. Examples of polarizing plates attached to the outer surface of the liquid crystal cell include: a polarizing plate made of a polarizing film called "H film" obtained by sandwiching a cellulose acetate protective film and extending and aligning polyvinyl alcohol to absorb iodine, or a polarizing plate composed of the H film itself.

係IPS方式(模式)使用之梳齒電極基板的IPS基板,具有:基材;形成於基材上且配置成梳齒狀之多個線狀電極;及在基材上以被覆線狀電極之方式形成之液晶配向膜。The IPS substrate is a comb-tooth electrode substrate used in the IPS method (mode), comprising: a substrate; a plurality of linear electrodes formed on the substrate and arranged in a comb-tooth shape; and a liquid crystal alignment film formed on the substrate in a manner of covering the linear electrodes.

又,係FFS方式(模式)之梳齒電極基板的FFS基板,具有:基材;形成於基材上之面電極;形成於面電極上之絕緣膜;形成在絕緣膜上且配置成梳齒狀之多個線狀電極;及在絕緣膜上以被覆線狀電極之方式形成之液晶配向膜。In addition, the FFS substrate is a comb-tooth electrode substrate of the FFS method (mode), which has: a substrate; a surface electrode formed on the substrate; an insulating film formed on the surface electrode; a plurality of linear electrodes formed on the insulating film and arranged in a comb-tooth shape; and a liquid crystal alignment film formed on the insulating film in a manner of covering the linear electrodes.

圖1係顯示具有由本發明之液晶配向劑獲得之液晶配向膜之IPS模式之橫電場液晶顯示元件之一例之概略剖面圖。FIG. 1 is a schematic cross-sectional view showing an example of an IPS mode transverse electric field liquid crystal display element having a liquid crystal alignment film obtained using the liquid crystal alignment agent of the present invention.

圖1例示之橫電場液晶顯示元件1中,在具備液晶配向膜2c之梳齒電極基板2與具備液晶配向膜4a之對向基板4之間夾持著液晶3。梳齒電極基板2具有:基材2a;形成在基材2a上且配置成梳齒狀之多個線狀電極2b;在基材2a上以被覆線狀電極2b之方式形成之液晶配向膜2c。對向基板4,具有基材4b及形成在基材4b上之液晶配向膜4a。液晶配向膜2c為本發明之液晶配向膜。液晶配向膜4c也同樣是本發明之液晶配向膜。In the transverse electric field liquid crystal display element 1 illustrated in FIG1 , a liquid crystal 3 is sandwiched between a comb-tooth electrode substrate 2 having a liquid crystal alignment film 2c and an opposing substrate 4 having a liquid crystal alignment film 4a. The comb-tooth electrode substrate 2 has: a substrate 2a; a plurality of linear electrodes 2b formed on the substrate 2a and arranged in a comb shape; and a liquid crystal alignment film 2c formed on the substrate 2a in a manner of covering the linear electrodes 2b. The opposing substrate 4 has a substrate 4b and a liquid crystal alignment film 4a formed on the substrate 4b. The liquid crystal alignment film 2c is the liquid crystal alignment film of the present invention. The liquid crystal alignment film 4c is also the liquid crystal alignment film of the present invention.

圖1之橫電場液晶顯示元件1中,若對於線狀電極2b施加電壓,會如電力線L所示,在線狀電極2b間產生電場。In the transverse electric field liquid crystal display element 1 of FIG. 1 , when a voltage is applied to the linear electrodes 2 b , an electric field is generated between the linear electrodes 2 b as indicated by electric field lines L.

圖2,係顯示具備從本發明之液晶配向劑獲得之液晶配向膜之FFS模式之橫電場液晶顯示元件之一例之概略剖面圖。FIG. 2 is a schematic cross-sectional view showing an example of a FFS mode transverse electric field liquid crystal display element having a liquid crystal alignment film obtained from the liquid crystal alignment agent of the present invention.

圖2例示之橫電場液晶顯示元件1中,在具備液晶配向膜2h之梳齒電極基板2與具備液晶配向膜4a之對向基板4之間,夾持著液晶3。梳齒電極基板2,具有:基材2d;形成在基材2d上之面電極2e;形成在面電極2e上之絕緣膜2f;及形成在絕緣膜2f上且配置成梳齒狀之多個線狀電極2g;及在絕緣膜2f上以被覆線狀電極2g之方式形成之液晶配向膜2h。對向基板4,具有:基材4b,及形成在基材4b上之液晶配向膜4a。液晶配向膜2h為本發明之液晶配向膜。液晶配向膜4a也同樣為本發明之液晶配向膜。In the transverse electric field liquid crystal display element 1 illustrated in FIG2 , liquid crystal 3 is sandwiched between a comb-tooth electrode substrate 2 having a liquid crystal alignment film 2h and an opposing substrate 4 having a liquid crystal alignment film 4a. The comb-tooth electrode substrate 2 comprises: a substrate 2d; a surface electrode 2e formed on the substrate 2d; an insulating film 2f formed on the surface electrode 2e; and a plurality of linear electrodes 2g formed on the insulating film 2f and arranged in a comb shape; and a liquid crystal alignment film 2h formed on the insulating film 2f in a manner of covering the linear electrodes 2g. The opposing substrate 4 comprises: a substrate 4b and a liquid crystal alignment film 4a formed on the substrate 4b. The liquid crystal alignment film 2h is the liquid crystal alignment film of the present invention. The liquid crystal alignment film 4a is also the liquid crystal alignment film of the present invention.

圖2之橫電場液晶顯示元件1中,若對於面電極2e及線狀電極2g施加電壓,則會如電力線L所示,在面電極2e及線狀電極2g間產生電場。 [實施例] In the transverse electric field liquid crystal display element 1 of FIG. 2 , if a voltage is applied to the surface electrode 2e and the linear electrode 2g, an electric field will be generated between the surface electrode 2e and the linear electrode 2g as shown by the electric field lines L. [Example]

以下舉實施例對於本發明更具體說明,但本發明不限於此等。以下化合物之簡稱及各特性之測定方法如下所示。 (有機溶劑) NMP:N-甲基-2-吡咯烷酮 BCS:乙二醇單丁醚 (四羧酸二酐) CA-1~CA-2:各為下式(CA-1)~(CA-2)表示之化合物 (二胺) DA-1~DA-8:各為下式(DA-1)~(DA-8)表示之化合物 The following examples are given to illustrate the present invention in more detail, but the present invention is not limited thereto. The abbreviations of the following compounds and the methods for measuring the properties are as follows. (Organic solvent) NMP: N-methyl-2-pyrrolidone BCS: Ethylene glycol monobutyl ether (Tetracarboxylic dianhydride) CA-1~CA-2: Each is a compound represented by the following formula (CA-1)~(CA-2) (Diamine) DA-1~DA-8: Each is a compound represented by the following formula (DA-1)~(DA-8)

[化38] [Chemistry 38]

<黏度之測定> 使用E型黏度計TVE-22H(東機產業公司製),樣本量1.1mL,使用錐形轉子TE-1(1°34’、R24),於溫度25℃進行測定。 <分子量之測定> 以下列常溫GPC(凝膠滲透層析)裝置測定,就聚乙二醇、聚環氧乙烷換算值算出Mn及Mw。 <Viscosity measurement> Use E-type viscometer TVE-22H (manufactured by Toki Sangyo Co., Ltd.), sample volume 1.1mL, use conical rotor TE-1 (1°34', R24), and measure at 25°C. <Molecular weight measurement> Measured with the following room temperature GPC (gel permeation chromatography) device, Mn and Mw were calculated based on polyethylene glycol and polyethylene oxide conversion values.

GPC裝置:GPC-101(昭和電工公司製)、管柱:GPC KD-803、GPC KD-805(昭和電工公司製)之串聯、管柱溫度:50℃、溶離液:N,N-二甲基甲醯胺(添加劑為溴化鋰一水合物(LiBr・H 2O)為30mmol/L、磷酸無水結晶(正磷酸)為30mmol/L、四氫呋喃(THF)為10mL/L)、流速:1.0mL/分 檢量線作成用標準樣本:TSK 標準聚環氧乙烷(分子量;約900,000、約150,000、約100,000及約30,000)(東曹公司製)及聚乙二醇(分子量;約12,000、約4,000及約1,000)(Polymer Laboratory Corporation製)。 [聚合物之合成] <合成例1> 於附攪拌裝置及氮氣導入管之100mL四口燒瓶中加入DA-1(1.08g、8.86mmol)、DA-2(2.16g、8.86mmol)、DA-3(1.89g、5.91mmol)、DA-4(2.35g、5.90mmol)、CA-1(6.22g、27.8mmol)及NMP(100g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(A-1)之溶液(黏度:372mPa・s)。此聚醯胺酸之Mn為12,042、Mw為39,532。 <合成例2> 於附攪拌裝置及氮氣導入管之100mL四口燒瓶中加入DA-5(1.21g、8.86mmol)、DA-2(2.16g、8.86mmol)、DA-3(1.89g、5.91mmol)、DA-4(2.35g、5.90mmol)、CA-1(6.22g、27.8mmol)及NMP(101g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(A-2)之溶液(黏度:367mPa・s)。此聚醯胺酸之Mn為12,001,Mw為40,211。 <合成例3> 於附攪拌裝置及氮氣導入管之100mL四口燒瓶中加入DA-8(1.21g、8.86mmol)、DA-2(2.16g、8.86mmol)、DA-3(1.89g、5.91mmol)、DA-4(2.35g、5.90mmol)、CA-1(6.22g、27.8mmol)及NMP(101g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(A-3)之溶液(黏度:367mPa・s)。此聚醯胺酸之Mn為12,001,Mw為40,211。 <合成例4> 於附攪拌裝置及氮氣導入管之100mL四口燒瓶中加入\DA-6(1.28g、11.8mmol)、DA-7(5.29g、17.7mmol)、CA-2(5.44g、27.8mmol)及NMP(88.1g),於室溫攪拌3小時,獲得固體成分濃度12質量%之聚醯胺酸(B-1)之溶液(黏度:130mPa・s)。此聚醯胺酸之Mn為10,100,Mw為37,822。 GPC apparatus: GPC-101 (manufactured by Showa Denko Co., Ltd.), column: GPC KD-803, GPC KD-805 (manufactured by Showa Denko Co., Ltd.) in series, column temperature: 50°C, solvent: N,N-dimethylformamide (additives: lithium bromide monohydrate (LiBr・H 2 O) 30 mmol/L, anhydrous phosphoric acid (orthophosphoric acid) 30 mmol/L, tetrahydrofuran (THF) 10 mL/L), flow rate: 1.0 mL/min. Standard samples for calibration curve preparation: TSK standard polyethylene oxide (molecular weight: about 900,000, about 150,000, about 100,000 and about 30,000) (manufactured by Tosoh Co., Ltd.) and polyethylene glycol (molecular weight: about 12,000, about 4,000 and about 1,000) (Polymer Laboratory Corporation). [Synthesis of polymer] <Synthesis Example 1> DA-1 (1.08 g, 8.86 mmol), DA-2 (2.16 g, 8.86 mmol), DA-3 (1.89 g, 5.91 mmol), DA-4 (2.35 g, 5.90 mmol), CA-1 (6.22 g, 27.8 mmol) and NMP (100 g) were added to a 100 mL four-necked flask equipped with a stirring device and a nitrogen inlet tube, and stirred at 40°C for 20 hours to obtain a solution of polyamide (A-1) with a solid content concentration of 12 mass% (viscosity: 372 mPa・s). The Mn of this polyamide is 12,042 and the Mw is 39,532. <Synthesis Example 2> DA-5 (1.21 g, 8.86 mmol), DA-2 (2.16 g, 8.86 mmol), DA-3 (1.89 g, 5.91 mmol), DA-4 (2.35 g, 5.90 mmol), CA-1 (6.22 g, 27.8 mmol) and NMP (101 g) were added to a 100 mL four-necked flask equipped with a stirring device and a nitrogen inlet tube, and stirred at 40°C for 20 hours to obtain a solution of polyamide (A-2) with a solid content concentration of 12 mass % (viscosity: 367 mPa・s). The Mn of this polyamide is 12,001 and the Mw is 40,211. <Synthesis Example 3> DA-8 (1.21 g, 8.86 mmol), DA-2 (2.16 g, 8.86 mmol), DA-3 (1.89 g, 5.91 mmol), DA-4 (2.35 g, 5.90 mmol), CA-1 (6.22 g, 27.8 mmol) and NMP (101 g) were added to a 100 mL four-necked flask equipped with a stirring device and a nitrogen inlet tube, and stirred at 40°C for 20 hours to obtain a solution of polyamide (A-3) with a solid content concentration of 12 mass % (viscosity: 367 mPa・s). The Mn of this polyamide is 12,001 and the Mw is 40,211. <Synthesis Example 4> DA-6 (1.28 g, 11.8 mmol), DA-7 (5.29 g, 17.7 mmol), CA-2 (5.44 g, 27.8 mmol) and NMP (88.1 g) were added to a 100 mL four-necked flask equipped with a stirring device and a nitrogen inlet tube, and stirred at room temperature for 3 hours to obtain a solution of polyamide (B-1) with a solid content concentration of 12 mass % (viscosity: 130 mPa・s). The Mn of this polyamide is 10,100 and the Mw is 37,822.

合成例1~4使用之四羧酸衍生物成分及二胺成分之種類及量,彙整示於表1。表1中,括弧內之數值,代表相對於各成分中之合計100莫耳份之單體之使用量(莫耳份)。The types and amounts of the tetracarboxylic acid derivative components and diamine components used in Synthesis Examples 1 to 4 are summarized in Table 1. In Table 1, the values in parentheses represent the amount (in moles) of the monomers used relative to 100 moles of the total monomers in each component.

[表1] 合成例 聚醯胺酸 四羧酸成分 二胺成分 特定二胺 其他二胺 1 A-1 CA-1 (100) DA-1 (30) DA-2 (30) DA-3 (20) DA-4 (20) - 2 A-2 CA-1 (100) - DA-2 (30) DA-3 (20) DA-4 (20) DA-5 (30) 3 A-3 CA-1 (100) DA-8 (30) DA-2 (30) DA-3 (20) DA-4 (20) - 4 B-1 CA-2 (100) - DA-6 (40) DA-7 (60) - - [Table 1] Synthesis Example Polyamine Tetracarboxylic acid components Diamine component Specific diamine Other diamines 1 A-1 CA-1 (100) DA-1 (30) DA-2 (30) DA-3 (20) DA-4 (20) - 2 A-2 CA-1 (100) - DA-2 (30) DA-3 (20) DA-4 (20) DA-5 (30) 3 A-3 CA-1 (100) DA-8 (30) DA-2 (30) DA-3 (20) DA-4 (20) - 4 B-1 CA-2 (100) - DA-6 (40) DA-7 (60) - -

<液晶配向劑之製備> (實施例1) 於上述聚合物之溶液(A-1)(5.00g)加入聚合物之溶液(B-1)(7.50g)及NMP(8.50g)及BCS(9.00g),於室溫攪拌2小時,以獲得液晶配向劑(V-1)。 (比較例1) 於上述聚合物之溶液(A-2)(5.00g)加入聚合物之溶液(B-1)(7.50g)及NMP(8.50g)及BCS(9.00g),於室溫攪拌2小時,以獲得液晶配向劑(RV-1)。 <Preparation of liquid crystal alignment agent> (Example 1) Add the polymer solution (B-1) (7.50 g), NMP (8.50 g) and BCS (9.00 g) to the above polymer solution (A-1) (5.00 g), stir at room temperature for 2 hours to obtain a liquid crystal alignment agent (V-1). (Comparative Example 1) Add the polymer solution (B-1) (7.50 g), NMP (8.50 g) and BCS (9.00 g) to the above polymer solution (A-2) (5.00 g), stir at room temperature for 2 hours to obtain a liquid crystal alignment agent (RV-1).

上述實施例1、及比較例1獲得之液晶配向劑之規格示於表2。聚合物成分中之括弧內之數值,代表相對於聚合物成分之合計100質量份之各聚合物成分之導入量(質量份)。The specifications of the liquid crystal alignment agents obtained in the above-mentioned Example 1 and Comparative Example 1 are shown in Table 2. The values in parentheses in the polymer components represent the amount (parts by mass) of each polymer component introduced relative to 100 parts by mass of the total polymer components.

[表2]   液晶 配向劑 聚合物成分 固體成分 [質量%] 溶劑組成[質量%] NMP BCS 實施例1 V-1 A-1 (40) B-1 (60) 5 65 30 比較例1 RV-1 A-2 (40) B-1 (60) 5 65 30 [Table 2] Liquid crystal alignment agent Polymer composition Solid content [mass %] Solvent composition [mass %] NMP BCS Embodiment 1 V-1 A-1 (40) B-1 (60) 5 65 30 Comparison Example 1 RV-1 A-2 (40) B-1 (60) 5 65 30

[FFS驅動液晶胞之製作] (實施例2-1) 製作具備FFS模式液晶顯示元件之構成之液晶胞。 [Fabrication of FFS-driven liquid crystal cell] (Example 2-1) Fabricate a liquid crystal cell having the structure of a FFS mode liquid crystal display element.

首先準備附電極之基板。基板係使用30mm×50mm之長方形且厚度為0.7mm之玻璃基板。基板上形成了作為第1層之構成共通電極之具備滿版狀之圖案之ITO電極。第1層之共通電極之上形成了作為第2層之以CVD(化學蒸鍍)法成膜之SiN(氮化矽)膜。第2層之SiN膜之膜厚為300nm,作為層間絕緣膜作用。第2層之SiN膜之上,配置了做為第3層之ITO膜圖案化形成之梳齒狀之畫素電極,形成了第1畫素及第2畫素2個畫素,各畫素之尺寸為縱10mm、橫5mm。本附電極之基板,具有第1層之共通電極與第3層之畫素電極以第2層之SiN膜絕緣的結構。First, prepare a substrate with electrodes. The substrate is a glass substrate with a rectangular shape of 30mm×50mm and a thickness of 0.7mm. An ITO electrode with a full-plate pattern is formed on the substrate as the first layer constituting the common electrode. A SiN (silicon nitride) film formed by CVD (chemical evaporation) is formed as the second layer on the first layer of the common electrode. The second layer of SiN film has a thickness of 300nm and acts as an interlayer insulating film. On the second layer of SiN film, a comb-shaped pixel electrode formed by patterning the ITO film as the third layer is arranged, forming two pixels, the first pixel and the second pixel, and the size of each pixel is 10mm in length and 5mm in width. The substrate with electrodes has a structure in which a common electrode on the first layer and a pixel electrode on the third layer are insulated by a SiN film on the second layer.

第3層的畫素電極,具有中央部分以內角160°彎折且寬3μm之電極線以6μm的間隔成平行排列多條的梳齒形狀,1個畫素由多個電極線形成,以連結彎折部之線為界,具有第1區及第2區。The pixel electrode of the third layer has a comb shape in which a plurality of electrode lines with a width of 3 μm are arranged in parallel at intervals of 6 μm and the central portion is bent at an internal angle of 160°. One pixel is formed by a plurality of electrode lines and has a first region and a second region bounded by a line connecting the bent portions.

然後將上述實施例1獲得之液晶配向劑(V-1)以孔徑1.0μm之濾器過濾後,以旋塗法塗佈在上述附電極支基板(以後,稱為電極基板)、及背面成膜了ITO膜之具有高度4μm之柱狀間隔件之玻璃基板(以後,稱為對向基板)。在80℃之熱板上乾燥2分鐘後,以230℃之熱風循環式烘箱進行20分鐘煅燒,形成膜厚100nm之塗膜。於此塗膜面隔著254nm帶通濾器及偏光子照射偏光紫外線,再於230℃之IR烘箱進行0分鐘煅燒,實施配向處理,獲得附液晶配向膜之基板。照射量示於下列表3。又,對於上述電極基板形成之液晶配向膜,實施了配向處理,使將畫素彎折部之內角等分之方向與液晶之配向方向成直交,對於對向基板形成之配向膜,實施配向處理,使製作液晶胞時電極基板上之液晶之配向方向與對向基板上之液晶之配向方向一致。將上述2片基板作為一組,以分配器於基板上印刷密封劑(三井化學公司製XN-1500T),並貼合另1片基板,使各液晶配向膜之配向方向成為0°而彼此面對。之後,壓接已貼合之基板,以150℃之熱風循環式烘箱加熱60分鐘,使密封劑硬化,製作空胞。於此空胞利用減壓注入法注入負型液晶MLC-7026-100(默克公司製),將注入口密封,以獲得FFS驅動液晶胞。之後,將獲得之液晶胞於120℃加熱1小時,於23℃放置一晩。以目視觀察,結果液晶胞內之液晶係均勻配向。 (比較例2-1) 將液晶配向劑變更為比較例1獲得之液晶配向劑(RV-1),除此以外依和實施例(2-1)同樣的程序製作液晶胞。以目視觀察,結果液晶胞內之液晶係均勻配向。 [膜硬度之評價] (實施例3-1) 將上述實施例1獲得之液晶配向劑(V-1)以旋塗法塗佈在ITO基板。於80℃之熱板上乾燥2分鐘後,於230℃之IR烘箱進行30分鐘煅燒,形成厚度100nm之塗膜。對於此塗膜面以400mJ/cm 2隔著偏光板照射經消光比26:1之直線偏光之波長254nm之紫外線而實施配向處理,再於230℃之IR烘箱進行30分鐘煅燒,獲得附液晶配向膜之基板。之後,將液晶配向膜使用縲縈布(Hyperflex公司製,HY-5318)進行摩擦配向處理(輥直徑:120mm、輥轉速:1000rpm、移動速度:20mm/sec、推入長度:0.5mm),並以霧度計(SUGA試驗機公司製,HZ-V3)評價膜的霧度值(濁度)。霧度值越小,則膜越未被削薄,亦即可說膜硬度高。針對評價基準,霧度值未達0.10時評為「○」,0.10以上時評為「×」。結果示於表3。 (比較例3-1) 液晶配向劑變更為比較例1獲得之液晶配向劑(RV-1),除此以外依和實施例(3-1)同樣的程序進行膜硬度之評價。結果示於表3。 Then, the liquid crystal alignment agent (V-1) obtained in the above-mentioned Example 1 is filtered through a filter with an aperture of 1.0μm, and then coated on the above-mentioned electrode support substrate (hereinafter referred to as the electrode substrate) and the glass substrate with a columnar spacer with a height of 4μm and an ITO film formed on the back (hereinafter referred to as the opposite substrate) by spin coating. After drying on a hot plate at 80°C for 2 minutes, it is calcined in a hot air circulation oven at 230°C for 20 minutes to form a coating with a film thickness of 100nm. The coated surface is irradiated with polarized ultraviolet light through a 254nm bandpass filter and polarized light, and then calcined in an IR oven at 230°C for 0 minutes to perform alignment treatment to obtain a substrate with a liquid crystal alignment film. The irradiation amount is shown in the following Table 3. Furthermore, the liquid crystal alignment film formed on the electrode substrate was subjected to an alignment treatment so that the direction of dividing the inner angle of the pixel bend into equal parts was perpendicular to the alignment direction of the liquid crystal. The alignment film formed on the opposite substrate was subjected to an alignment treatment so that the alignment direction of the liquid crystal on the electrode substrate was consistent with the alignment direction of the liquid crystal on the opposite substrate when the liquid crystal cell was made. The two substrates were grouped together, and a sealant (XN-1500T manufactured by Mitsui Chemicals, Inc.) was printed on the substrates using a dispenser, and another substrate was bonded so that the alignment direction of each liquid crystal alignment film was 0° and faced each other. After that, the bonded substrates were pressed together and heated in a hot air circulation oven at 150°C for 60 minutes to harden the sealant and make a cell. In this empty cell, negative liquid crystal MLC-7026-100 (Merck) is injected by reduced pressure injection method, and the injection port is sealed to obtain an FFS-driven liquid crystal cell. Afterwards, the obtained liquid crystal cell is heated at 120°C for 1 hour and placed at 23°C overnight. Visual observation shows that the liquid crystal in the liquid crystal cell is uniformly aligned. (Comparative Example 2-1) The liquid crystal alignment agent is changed to the liquid crystal alignment agent (RV-1) obtained in Comparative Example 1, and a liquid crystal cell is prepared according to the same procedure as Example (2-1). Visual observation shows that the liquid crystal in the liquid crystal cell is uniformly aligned. [Evaluation of film hardness] (Example 3-1) The liquid crystal alignment agent (V-1) obtained in Example 1 was applied to an ITO substrate by spin coating. After drying on a hot plate at 80°C for 2 minutes, it was calcined in an IR oven at 230°C for 30 minutes to form a coating with a thickness of 100 nm. The coating surface was irradiated with 400 mJ/ cm2 of linearly polarized ultraviolet light with an extinction ratio of 26:1 through a polarizing plate to perform an alignment treatment, and then calcined in an IR oven at 230°C for 30 minutes to obtain a substrate with a liquid crystal alignment film. Afterwards, the liquid crystal alignment film was rubbed and aligned using a spun cloth (HY-5318, manufactured by Hyperflex) (roller diameter: 120 mm, roller speed: 1000 rpm, moving speed: 20 mm/sec, push length: 0.5 mm), and the haze value (turbidity) of the film was evaluated using a haze meter (HZ-V3, manufactured by SUGA Testing Instrument Co., Ltd.). The smaller the haze value, the less thinned the film is, which means that the film hardness is high. Based on the evaluation criteria, a haze value of less than 0.10 was rated as "○", and a haze value of more than 0.10 was rated as "×". The results are shown in Table 3. (Comparative Example 3-1) The film hardness was evaluated in the same manner as in Example (3-1) except that the liquid crystal alignment agent was changed to the liquid crystal alignment agent (RV-1) obtained in Comparative Example 1. The results are shown in Table 3.

[表3]   液晶 配向劑 紫外線照射量 (J/cm 2) 膜硬度 實施例3-1 V-1 0.4 0.07 (〇) 比較例3-1 RV-1 0.4 0.10 (×) [table 3] Liquid crystal alignment agent UV exposure (J/cm 2 ) Film hardness Example 3-1 V-1 0.4 0.07 (○) Comparative Example 3-1 RV-1 0.4 0.10 (×)

由上述表3可知,由使用特定二胺之液晶配向劑獲得之液晶配向膜,相較於由以不含特定二胺之成分構成之液晶配向劑獲得之液晶配向膜,膜硬度較為優異。 [產業利用性] As can be seen from Table 3 above, the liquid crystal alignment film obtained by using a liquid crystal alignment agent containing a specific diamine has a better film hardness than the liquid crystal alignment film obtained by using a liquid crystal alignment agent containing no specific diamine. [Industrial Applicability]

藉由使用本發明之液晶配向劑,可獲得即使使用經取代之環丁烷四羧酸二酐或其衍生物為原料獲得之聚醯亞胺液晶配向膜仍為具高機械強度之液晶配向膜。所以,可期待在要求高顯示品位之液晶顯示元件,尤其IPS驅動方式、FFS驅動方式之液晶顯示元件的利用。並且,該等元件在以顯示為目的之液晶顯示器、控制光透射及遮斷之調光窗、光閘等亦為有用。By using the liquid crystal alignment agent of the present invention, a polyimide liquid crystal alignment film can be obtained, which is a liquid crystal alignment film with high mechanical strength even if substituted cyclobutane tetracarboxylic dianhydride or its derivatives are used as raw materials. Therefore, it can be expected to be used in liquid crystal display elements requiring high display quality, especially liquid crystal display elements of IPS drive mode and FFS drive mode. In addition, these elements are also useful in liquid crystal displays for display purposes, dimming windows for controlling light transmission and blocking, light gates, etc.

1:橫電場液晶顯示元件 2:梳齒電極基板 2a:基材 2b:線狀電極 2c:液晶配向膜 2d:基材 2e:面電極 2f:絕緣膜 2g:線狀電極 2h:液晶配向膜 3:液晶 4:對向基板 4a:液晶配向膜 4b:基材 L:電力線 1: Transverse electric field liquid crystal display element 2: Comb electrode substrate 2a: Substrate 2b: Linear electrode 2c: Liquid crystal alignment film 2d: Substrate 2e: Surface electrode 2f: Insulating film 2g: Linear electrode 2h: Liquid crystal alignment film 3: Liquid crystal 4: Counter substrate 4a: Liquid crystal alignment film 4b: Substrate L: Electric line

圖1係具備由本發明之液晶配向劑獲得之液晶配向膜之橫電場液晶顯示元件之一例之概略剖面圖。 圖2係具備由本發明之液晶配向劑獲得之液晶配向膜之橫電場液晶顯示元件之另一例之概略剖面圖。 FIG1 is a schematic cross-sectional view of one example of a transverse electric field liquid crystal display element having a liquid crystal alignment film obtained by the liquid crystal alignment agent of the present invention. FIG2 is a schematic cross-sectional view of another example of a transverse electric field liquid crystal display element having a liquid crystal alignment film obtained by the liquid crystal alignment agent of the present invention.

1:橫電場液晶顯示元件 1: Transverse electric field liquid crystal display element

2:梳齒電極基板 2: Comb electrode substrate

2a:基材 2a: Base material

2b:線狀電極 2b: Linear electrode

2c:液晶配向膜 2c: Liquid crystal alignment film

3:液晶 3: Liquid crystal

4:對向基板 4: Opposite substrate

4a:液晶配向膜 4a: Liquid crystal alignment film

4b:基材 4b: Base material

L:電力線 L: Power lines

Claims (17)

一種液晶配向劑,其特徵為含有聚合物(A),該聚合物(A)係選自於由具有下式(1)表示之重複單元(a1)之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種, R及Z各自獨立地表示氫原子或1價有機基。 A liquid crystal alignment agent, characterized in that it contains a polymer (A), wherein the polymer (A) is at least one selected from the group consisting of a polyimide precursor having a repeating unit (a1) represented by the following formula (1) and a polyimide which is an imide compound of the polyimide precursor. R and Z each independently represent a hydrogen atom or a monovalent organic group. 如請求項1之液晶配向劑,其中,該聚合物(A)係選自於由更具有下式(2)表示之重複單元(a2)之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物, 式(2)中,R、及Z和該式(1)之情形為同義,Y 2表示下式(O)表示之2價有機基, 式(O)中,Ar各自獨立地表示苯環、聯苯結構、或萘環,該Ar之環上之任意氫原子也可被鹵素原子或1價有機基取代,Q 2表示-(CH 2) n-(n為2~18)、或該-(CH 2) n-之一部分被-O-、-C(=O)-及-O-C(=O)-中之任一者取代之基,*表示原子鍵。 The liquid crystal alignment agent of claim 1, wherein the polymer (A) is at least one polymer selected from the group consisting of a polyimide precursor having a repeating unit (a2) represented by the following formula (2) and a polyimide which is an imide compound of the polyimide precursor, In formula (2), R and Z have the same meanings as in formula (1), and Y2 represents a divalent organic group represented by the following formula (O), In formula (O), Ar each independently represents a benzene ring, a biphenyl structure, or a naphthyl ring, any hydrogen atom on the Ar ring may be substituted by a halogen atom or a monovalent organic group, Q2 represents -( CH2 ) n- (n is 2 to 18), or a group in which a part of -( CH2 ) n- is substituted by any one of -O-, -C(=O)- and -OC(=O)-, and * represents an atomic bond. 如請求項2之液晶配向劑,其中,該式(O)表示之2價有機基係下式(o-1)~(o-15)中之任一者表示之2價有機基, 式(o-1)~(o-14)中,*表示原子鍵,式(o-14)~(o-15)中,2個m各自獨立。 The liquid crystal alignment agent of claim 2, wherein the divalent organic group represented by the formula (O) is a divalent organic group represented by any one of the following formulas (o-1) to (o-15), In formulas (o-1) to (o-14), * represents an atomic bond, and in formulas (o-14) to (o-15), two m's are independent of each other. 如請求項1之液晶配向劑,其中,該聚合物(A)係選自於由更具有選自於由下式(2’)表示之重複單元(a2’)及下式(3)表示之重複單元(a3)構成之群組中之至少一者之聚醯亞胺前驅物及作為該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物, 式(2’)、(3)中,X 2’、X 3表示4價有機基,Y 2’表示下式(O2)表示之2價有機基,Y 3表示分子內具有基「-N(D)-,D表示胺甲酸酯系保護基」且排除D之碳數6~30之2價有機基,R、Z和上式(1)之情形為同義, 式(O2)中,m為0~2之整數,Ar 2’表示未經取代或經取代之苯環,惟m為0時,Ar 2’表示未經取代之苯環,m為1或2時,Ar 2’各自獨立地表示未經取代之苯環、或該苯環上之任意氫原子被鹵素原子或1價有機基取代之苯環中之任一者,Q 2’表示單鍵或-O-,*表示原子鍵,Ar 2’、Q 2’有多個存在時,各自可相同也可不同。 The liquid crystal alignment agent of claim 1, wherein the polymer (A) is at least one polymer selected from the group consisting of a polyimide precursor further comprising at least one selected from the group consisting of a repeating unit (a2') represented by the following formula (2') and a repeating unit (a3) represented by the following formula (3) and a polyimide which is an imide compound of the polyimide precursor, In formula (2') and (3), X 2' and X 3 represent a tetravalent organic group, Y 2' represents a divalent organic group represented by the following formula (O2), Y 3 represents a divalent organic group having a group "-N(D)-, D represents a carbamate protective group" in the molecule and excluding D, and having a carbon number of 6 to 30. R and Z have the same meaning as in the case of the above formula (1). In formula (O2), m is an integer of 0 to 2, Ar 2' represents an unsubstituted or substituted benzene ring, but when m is 0, Ar 2' represents an unsubstituted benzene ring, when m is 1 or 2, Ar 2' each independently represents an unsubstituted benzene ring, or a benzene ring in which any hydrogen atom on the benzene ring is substituted by a halogen atom or a monovalent organic group, Q 2' represents a single bond or -O-, * represents an atomic bond, and when multiple Ar 2' and Q 2' exist, they may be the same or different. 如請求項4之液晶配向劑,其中,該式(O2)表示之2價有機基係下式(o2-1)~(o2-12)中之任一者表示之2價有機基, 式(o2-1)~(o2-12)中,*表示原子鍵。 The liquid crystal alignment agent of claim 4, wherein the divalent organic group represented by the formula (O2) is a divalent organic group represented by any one of the following formulas (o2-1) to (o2-12), In formulas (o2-1) to (o2-12), * represents an atomic bond. 如請求項1之液晶配向劑,其中,該聚合物(A)中,該重複單元(a1)及該重複單元(a1)之醯亞胺化結構單元之合計含量為全部重複單元之10~95莫耳%。The liquid crystal alignment agent of claim 1, wherein in the polymer (A), the total content of the repeating unit (a1) and the imide structural unit of the repeating unit (a1) is 10-95 mol% of all the repeating units. 如請求項2之液晶配向劑,其中,該聚合物(A)中,該重複單元(a2)及該重複單元(a2)之醯亞胺化結構單元之合計含量為全部重複單元之10~90莫耳%。The liquid crystal alignment agent of claim 2, wherein in the polymer (A), the total content of the repeating unit (a2) and the imide structural unit of the repeating unit (a2) is 10-90 mol% of all the repeating units. 如請求項2之液晶配向劑,其中,該聚合物(A)中,該重複單元(a1)、該重複單元(a2)、下式(2’)表示之重複單元(a2’)及它們的醯亞胺化結構單元之合計含量為全部重複單元之30莫耳%以上, 式(2’)中,X 2’表示4價有機基,Y 2’表示下式(O2)表示之2價有機基,R、Z和上式(1)之情形為同義, 式(O2)中,m為0~2之整數,Ar 2’表示未經取代或經取代之苯環,惟m為0時,Ar 2’表示未經取代之苯環,m為1或2時,Ar 2’各自獨立地表示未經取代之苯環、或該苯環上之任意氫原子被鹵素原子或1價有機基取代之苯環中之任一者,Q 2’表示單鍵或-O-,*表示原子鍵,Ar 2’、Q 2’有多個存在時,各自可相同也可不同。 The liquid crystal alignment agent of claim 2, wherein in the polymer (A), the total content of the repeating unit (a1), the repeating unit (a2), the repeating unit (a2') represented by the following formula (2'), and the imidized structural units thereof is greater than 30 mol% of all the repeating units, In formula (2'), X 2' represents a tetravalent organic group, Y 2' represents a divalent organic group represented by the following formula (O2), and R and Z have the same meanings as in the above formula (1). In formula (O2), m is an integer of 0 to 2, Ar 2' represents an unsubstituted or substituted benzene ring, but when m is 0, Ar 2' represents an unsubstituted benzene ring, when m is 1 or 2, Ar 2' each independently represents an unsubstituted benzene ring, or a benzene ring in which any hydrogen atom on the benzene ring is substituted by a halogen atom or a monovalent organic group, Q 2' represents a single bond or -O-, * represents an atomic bond, and when multiple Ar 2' and Q 2' exist, they may be the same or different. 如請求項1之液晶配向劑,其中,該液晶配向劑更含有分子內沒有該重複單元(a1)之聚合物(B), 該聚合物(B)為具有選自由下式(5)表示之重複單元(b1)及該重複單元(b1)之醯亞胺化結構單元構成之群組中之至少1種重複單元之聚合物, 式(5)中,X 5為4價有機基,Y 5為2價有機基,R、Z各和上式(1)中之R、Z為同義。 The liquid crystal alignment agent of claim 1, wherein the liquid crystal alignment agent further comprises a polymer (B) having no repeating unit (a1) in the molecule, wherein the polymer (B) is a polymer having at least one repeating unit selected from the group consisting of a repeating unit (b1) represented by the following formula (5) and an imidized structural unit of the repeating unit (b1), In formula (5), X 5 is a tetravalent organic group, Y 5 is a divalent organic group, and R and Z are the same as R and Z in formula (1). 如請求項1至9中任一項之液晶配向劑,係在光配向處理法用之液晶配向膜中使用。The liquid crystal alignment agent of any one of claims 1 to 9 is used in a liquid crystal alignment film for photo-alignment treatment. 一種液晶配向膜,係由如請求項1至9中任一項之液晶配向劑獲得。A liquid crystal alignment film is obtained from the liquid crystal alignment agent of any one of claims 1 to 9. 一種液晶顯示元件,具備如請求項11之液晶配向膜。A liquid crystal display element comprises a liquid crystal alignment film as claimed in claim 11. 一種液晶顯示元件用之液晶配向膜之製造方法,包括下列步驟(1)~(3), 步驟(1):將如請求項1至9中任一項之液晶配向劑塗佈在基板上, 步驟(2):將已塗佈之液晶配向劑進行煅燒, 步驟(3):對於步驟(2)獲得之膜視需要進行配向處理。 A method for manufacturing a liquid crystal alignment film for a liquid crystal display element comprises the following steps (1) to (3), Step (1): applying a liquid crystal alignment agent as described in any one of claims 1 to 9 on a substrate, Step (2): calcining the applied liquid crystal alignment agent, Step (3): performing alignment treatment on the film obtained in step (2) as needed. 如請求項13之液晶配向膜之製造方法,其中,該配向處理為光配向處理。A method for manufacturing a liquid crystal alignment film as claimed in claim 13, wherein the alignment treatment is a photo-alignment treatment. 如請求項14之液晶配向膜之製造方法,其中,該光配向處理之放射線之照射量為100~1,500mJ/cm 2The method for manufacturing a liquid crystal alignment film of claim 14, wherein the radiation exposure in the photo-alignment treatment is 100-1,500 mJ/cm 2 . 如請求項13之液晶配向膜之製造方法,更包括對於在步驟(3)經配向處理之膜進行50~300℃之加熱處理之步驟(4)。The method for manufacturing a liquid crystal alignment film as claimed in claim 13 further includes a step (4) of heating the film that has been aligned in step (3) at a temperature of 50-300°C. 如請求項13之液晶配向膜之製造方法,其中,該液晶顯示元件為IPS驅動方式或FFS驅動方式之液晶顯示元件。A method for manufacturing a liquid crystal alignment film as claimed in claim 13, wherein the liquid crystal display element is an IPS driven liquid crystal display element or an FFS driven liquid crystal display element.
TW112128726A 2022-08-05 2023-08-01 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element capable of obtaining a liquid crystal alignment film having high mechanical strength TW202411409A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-125634 2022-08-05
JP2022125634A JP2024022213A (en) 2022-08-05 2022-08-05 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Publications (1)

Publication Number Publication Date
TW202411409A true TW202411409A (en) 2024-03-16

Family

ID=89744523

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112128726A TW202411409A (en) 2022-08-05 2023-08-01 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element capable of obtaining a liquid crystal alignment film having high mechanical strength

Country Status (3)

Country Link
JP (1) JP2024022213A (en)
CN (1) CN117511567A (en)
TW (1) TW202411409A (en)

Also Published As

Publication number Publication date
CN117511567A (en) 2024-02-06
JP2024022213A (en) 2024-02-16

Similar Documents

Publication Publication Date Title
TWI864274B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI864241B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202415751A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP7800532B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW202436600A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN118377172A (en) Liquid crystal display element and method for manufacturing the same
TW202411409A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element capable of obtaining a liquid crystal alignment film having high mechanical strength
CN118355319A (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element and compound
CN117716282A (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, compound and polymer
CN117940842A (en) Liquid crystal alignment agent, liquid crystal alignment film, method for manufacturing liquid crystal display element, and liquid crystal display element
TWI890820B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI891844B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI878626B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI913414B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW202438651A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202436601A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202532394A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2024166693A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, compound and polymer
TW202436598A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202530380A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2024122359A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
WO2025121249A1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TW202532525A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2025177974A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TW202503029A (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element and manufacturing method thereof